Suggestive for eosinophilic asthma

ASTHMA_EOSINOPHIL_SUGG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions J10_ASTHMA	61122
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints J10_NASALPOLYP M13_CHURGSTRAUSS J10_PULMEOS Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT	3675
6. Filter based on genotype QC (FinnGen only)	3675

Control definitions (FinnGen only)

Control conditions: not J10_ASTHMA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_EOSINOPHIL_SUGG
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!J10_ASTHMA
SEX
INCLUDE	J10_NASALPOLYP\|M13_CHURGSTRAUSS\|J10_PULMEOS\|Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT
PRE_CONDITIONS
CONDITIONS	J10_ASTHMA
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Suggestive for eosinophilic asthma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	21151	9574	11468
Only index persons	19226	8895	10331
Unadjusted period prevalence (%)
Whole population	0.30	0.27	0.32
Only index persons	0.36	0.33	0.39
Median age at first event (years)
Whole population	51.33	50.38	52.09
Only index persons	50.40	49.51	51.17

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3675	1818	1857
Unadjusted period prevalence (%)	0.72	0.62	0.82
Median age at first event (years)	50.21	48.01	52.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3206: Matched controls
32058

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R03AK08

ATC

formoterol and beclometasone; inhalant

39.3

323.0

460

136

H02AB04

ATC

methylprednisolone; systemic

8.7

323.0

1229

2139

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

122.3

323.0

2671

1253

J45.1

ICD-10 Finland

Nonallergic asthma

317.8

323.0

1172

J45.0

ICD-10 Finland

Predominantly allergic asthma

206.4

323.0

1414

122

J33.9

ICD-10 Finland

Nasal polyp, unspecified

56.0

323.0

407

R01AD09

ATC

mometasone; nasal

7.7

323.0

2428

9213

R03AK06

ATC

salmeterol and fluticasone; inhalant

17.5

323.0

1385

1338

R03AC12

ATC

salmeterol; inhalant

45.5

323.0

602

162

R01AD08

ATC

fluticasone; nasal

22.4

323.0

2600

5156

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

45.1

323.0

1460

583

UDH02

NOMESCO Finland

Rhinopharyngoscopy

19.8

323.0

1066

786

TDM10

NOMESCO Finland

Puncture of maxillary antrum

28.1

323.0

784

365

J01.0

ICD-10 Finland

Acute maxillary sinusitis

5.4

323.0

1268

3453

DHB20

NOMESCO Finland

Polypectomy of internal nose

132.2

323.0

958

103

R03BA08

ATC

ciclesonide; inhalant

11.3

323.0

660

716

R03AK07

ATC

formoterol and budesonide; inhalant

10.3

323.0

1489

2481

R96

ICPC

Asthma

21.3

323.0

894

572

J45.9

ICD-10 Finland

Asthma, unspecified

186.0

323.0

2520

619

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

66.5

323.0

1060

236

49300

ICD-8 Finland

Asthma, bronchiale

+∞

323.0

447

R01AD05

ATC

budesonide; nasal

11.5

323.0

875

1016

J46

ICD-10 Finland

Status asthmaticus

235.5

323.0

411

R01AD01

ATC

beclometasone; nasal

7.2

323.0

1193

2430

R03BA01

ATC

beclometasone; inhalant

12.5

323.0

1239

1541

R03AC03

ATC

terbutaline; inhalant

9.0

323.0

1049

1642

R03AC02

ATC

salbutamol; inhalant

21.2

323.0

2909

10130

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

23.6

323.0

655

345

J32.4

ICD-10 Finland

Chronic pansinusitis

97.1

323.0

652

H02AB06

ATC

prednisolone; systemic

21.5

323.0

2880

9333

H02AB07

ATC

prednisone; oral

6.9

323.0

1075

2189

R03BB04

ATC

tiotropium bromide; inhalant

11.8

323.0

850

950

R03BA02

ATC

budesonide; inhalant

13.8

323.0

1521

1965

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

23.7

323.0

1280

873

J33.0

ICD-10 Finland

Polyp of nasal cavity

180.9

323.0

1902

257

R03DA04

ATC

theophylline; systemic, rectal

19.7

323.0

538

324

R03BA05

ATC

fluticasone; inhalant

11.5

323.0

1453

2156

J45.8

ICD-10 Finland

Mixed asthma

227.9

323.0

434

R03DC03

ATC

montelukast; oral

26.2

323.0

1851

1590

R03AC13

ATC

formoterol; inhalant

25.9

323.0

577

269

J33.8

ICD-10 Finland

Other polyp of sinus

151.4

323.0

1473

179

J45

ICD-10 Finland

Asthma

28.2

323.0

1129

607

R01AD12

ATC

fluticasone furoate; nasal

4.5

313.8

1514

5296

UDM02

NOMESCO Finland

Sinoscopy

26.3

293.3

416

181

ZXA10

NOMESCO Finland

Bilateral

4.9

287.9

1153

3272

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

4.8

279.1

1158

3390

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

3.8

274.7

2157

11176

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

88.4

273.2

304

J01AA02

ATC

doxycycline; systemic

5.9

271.5

2912

20052

4222

FHL

Endonasal etmoidectomy

68.0

257.5

297

R06AE07

ATC

cetirizine; oral

3.6

255.0

1853

8776

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

82.0

253.7

285

R01BA52

ATC

pseudoephedrine, combinations; oral

3.7

245.3

1498

6094

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

19.0

233.8

368

217

J01FA10

ATC

azithromycin; systemic

3.4

225.6

2237

12918

DPA30

NOMESCO Finland

Sphenotomy

73.4

225.2

257

R06AX27

ATC

desloratadine; oral

3.7

213.3

1231

4644

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

212.9

202

XQ800

NOMESCO Finland

Prick test

7.9

210.4

517

758

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

18.0

203.9

327

201

XG474

NOMESCO Finland

Exhalation nntrogen oxide

25.9

202.3

287

121

R03AK11

ATC

formoterol and fluticasone; inhalant

25.4

192.7

275

118

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

42.4

191.2

240

J01FA06

ATC

roxithromycin; oral

3.1

190.7

1671

8395

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

186.5

186.0

193

R01AD11

ATC

triamcinolone; nasal

5.5

175.5

574

1218

J31.0

ICD-10 Finland

Chronic rhinitis

6.0

174.6

528

1018

R03DC01

ATC

zafirlukast; oral

38.8

172.8

221

J01FA09

ATC

clarithromycin; systemic

3.1

172.4

1355

6189

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

8.4

171.9

403

540

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.7

157.4

817

2706

R06AE09

ATC

levocetirizine; oral

4.0

155.4

722

2170

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

3.1

154.0

1130

4839

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

8.8

153.9

349

440

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

779.3

152.6

149

50503

ICD-8 Finland

Nasal polyp, Ethmoidalis

101.0

148.6

163

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

148.1

141

J34.2

ICD-10 Finland

Deviated nasal septum

6.2

145.0

421

761

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

18.0

142.8

228

136

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

139.6

133

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

4.5

139.3

552

1415

R06AX22

ATC

ebastine; oral

3.4

136.0

780

2754

J01CA04

ATC

amoxicillin; systemic

3.1

132.1

2720

20730

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

44.5

129.8

161

R06AX13

ATC

loratadine; oral

3.5

128.4

699

2358

R06.0

ICD-10 Finland

Dyspnoea

2.9

125.8

952

4051

J01MA14

ATC

moxifloxacin; systemic

4.5

125.1

489

1228

DHB50

NOMESCO Finland

Turbinoplasty

9.3

123.6

268

310

XG410

NOMESCO Finland

Flow-volume spirometry

8.1

121.2

287

384

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.6

121.1

468

1159

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

120.6

115

DJD20

NOMESCO Finland

Plastic repair of septum of nose

6.9

119.7

317

501

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

119.2

934

4043

J33

ICD-10 Finland

Nasal polyp

32.3

117.9

157

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

158.4

116.1

122

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

114.0

1594

9453

J01FA15

ATC

telithromycin; oral

3.9

112.0

519

1516

J30.3

ICD-10 Finland

Other allergic rhinitis

9.1

108.4

238

280

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.4

108.2

304

519

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.5

105.8

264

381

H65.3

ICD-10 Finland

Chronic mucoid otitis media

13.1

105.5

191

154

4224

FHL

Endonasal anthrostomy

19.7

104.6

161

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

6.8

103.1

274

433

R06.2

ICD-10 Finland

Wheezing

7.9

103.0

246

332

J01DA06

ATC

[U] cefuroxime; systemic

3.1

102.4

661

2481

R06AX26

ATC

fexofenadine; oral

5.0

102.1

355

781

R02

ICPC

Shortness of breath/dyspnoea

3.6

100.2

512

1613

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

18.8

96.7

151

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

95.3

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

92.1

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

17.7

90.3

144

A02BC02

ATC

pantoprazole; systemic

2.2

90.1

2175

15813

J01DB01

ATC

cefalexin; oral

2.5

90.0

2704

21813

C01CA24

ATC

epinephrine; parenteral

5.1

87.8

297

630

4226

FHL

Posterior radical surgery and possible etmoidectomy

28.7

86.9

119

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.1

86.9

369

985

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.2

86.8

1380

8322

DHA10

NOMESCO Finland

Biopsy of cavity of nose

20.0

85.9

131

DMB10

NOMESCO Finland

Radical maxillary antrotomy

50.6

85.3

103

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.6

83.2

312

737

4732A

ICD-9 Finland

Chronic sinusitis, Ethmoidal

86.1

82.5

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

18.7

80.7

126

D72.1

ICD-10 Finland

Eosinophilia

36.3

79.0

102

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

205.0

77.6

J47

ICD-10 Finland

Bronchiectasis

11.9

77.5

146

128

J33.1

ICD-10 Finland

Polypoid sinus degeneration

140.2

77.3

DNB10

NOMESCO Finland

Endonasal ethmoidectomy

164.0

76.4

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

75.2

1270

7717

ZXC95

NOMESCO Finland

Use of surgical navigator

12.5

74.0

136

113

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

73.9

787

3875

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

10.3

73.5

149

151

N02BE01

ATC

paracetamol; systemic, rectal

2.4

70.6

2764

23239

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

46.4

70.2

R03BB01

ATC

ipratropium bromide; inhalant

6.4

67.8

187

308

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

28.1

67.8

J32.1

ICD-10 Finland

Chronic frontal sinusitis

34.8

67.6

R03BC03

ATC

nedocromil; inhalant

3.8

66.5

305

864

4719X

ICD-9 Finland

Nasal polyps, Unspecified nasal polyp

231.4

66.5

ZXE00

NOMESCO Finland

One hour or less

2.0

66.1

1341

8631

Z3231

NOMESCO Finland

Registered nurse

2.1

65.8

970

5493

J01DA01

ATC

[U] cefalexin; systemic

1.9

65.8

2042

15328

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.5

65.3

178

289

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.1

65.1

395

1388

J32.8

ICD-10 Finland

Other chronic sinusitis

37.0

64.7

J01.1

ICD-10 Finland

Acute frontal sinusitis

10.5

64.6

129

127

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

63.7

1313

8462

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.6

62.1

228

524

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

13.7

62.1

109

WX002

NOMESCO Finland

Sedation and analgesia

2.2

61.5

731

3747

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

61.3

955

5505

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

112.3

61.0

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

10.3

60.9

123

124

J01DC02

ATC

cefuroxime; systemic

3.8

60.9

278

783

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

5.7

60.3

181

332

J20

ICD-10 Finland

Acute bronchitis

3.1

59.9

370

1311

H65.2

ICD-10 Finland

Chronic serous otitis media

11.6

59.5

113

101

A01AB09

ATC

miconazole; local oral

3.2

59.1

339

1140

50304

ICD-8 Finland

Chronic sinusitis, Ethmoidalis

108.8

59.0

ZXD20

NOMESCO Finland

Day surgery

2.5

59.0

520

2288

Z2221

NOMESCO Finland

Medical doctor

2.0

58.8

955

5578

XG405

NOMESCO Finland

Education on PEF monitoring

15.3

58.5

J01MA12

ATC

levofloxacin; systemic

2.2

58.4

672

3380

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

36.5

58.4

J01.4

ICD-10 Finland

Acute pansinusitis

15.4

58.0

J01MA02

ATC

ciprofloxacin; systemic

1.9

57.5

1300

8566

A07AA02

ATC

nystatin; oral

3.7

57.1

269

777

S01GX01

ATC

cromoglicic acid; ophthalmic

2.3

55.7

625

3099

R09

ICPC

Sinus symptom/complaint

3.3

55.5

305

993

UDC00

NOMESCO Finland

Ear microscopy

3.1

55.4

327

1121

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

17.0

54.8

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

54.4

53.9

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

4.3

53.6

212

523

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

53.4

1472

10284

H66.0

ICD-10 Finland

Acute suppurative otitis media

3.7

52.8

250

724

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

52.4

326

1158

R03BC01

ATC

cromoglicic acid; inhalant

12.4

51.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

51.5

1012

6284

SPAT1058

SPAT

PEF monitoring instruction

3.1

51.5

307

1056

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

5.4

51.4

162

315

A02BC05

ATC

esomeprazole; systemic

1.8

51.2

1305

8846

3028

Kela drug reimbursment

Mepolizumab

+∞

51.2

297

Kela drug reimbursment

+∞

51.2

4239

FHL

Other measure in this category

19.7

50.6

N02AX02

ATC

tramadol; systemic, rectal

1.8

49.4

1342

9251

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

7.7

49.0

117

157

R05

ICD-10 Finland

Cough

2.1

46.7

615

3248

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.5

46.5

173

402

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

46.4

308

1138

J02AC01

ATC

fluconazole; systemic

1.8

46.4

1168

7817

R03DX09

ATC

mepolizumab; parenteral

+∞

45.9

R74

ICPC

Upper respiratory infection acute

1.9

45.5

825

4932

DHB40

NOMESCO Finland

Conchotomy

38.7

45.1

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

5.9

44.9

130

228

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

44.9

1166

7854

R05

ICPC

Cough

2.0

44.7

690

3881

DPA20

NOMESCO Finland

Trephine of frontal sinus

48.9

43.9

J01

ICD-10 Finland

Acute sinusitis

3.8

43.5

196

543

A02BC01

ATC

omeprazole; systemic

1.8

42.8

868

5375

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.4

42.7

133

255

G47.3

ICD-10 Finland

Sleep apnoea

1.9

42.7

717

4152

R01AC01

ATC

cromoglicic acid; nasal

4.5

42.2

156

360

SPAT1059

SPAT

Spirometry at the office

3.6

42.2

198

568

A02BC03

ATC

lansoprazole; oral

1.8

42.0

929

5916

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.0

41.9

257

900

WX110

NOMESCO Finland

Local anesthesy

1.7

40.9

2114

17178

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

7.1

40.3

101

146

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

40.1

421

1994

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

39.7

TGC00

NOMESCO Finland

Bronchial lavation

5.0

39.6

132

274

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

16.9

39.4

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

57.0

38.4

J01FF01

ATC

clindamycin; systemic

1.8

38.3

860

5476

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

10.1

38.2

R03AC04

ATC

fenoterol; inhalant

43.3

38.2

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

38.1

784

4847

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

37.8

895

5787

H66.9

ICD-10 Finland

Otitis media, unspecified

3.4

37.6

193

594

Z3226

NOMESCO Finland

Physiotherapist

1.9

37.2

589

3317

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

36.9

222

766

J01DA08

ATC

[U] cefaclor; oral

2.4

36.9

344

1538

R01BA51

ATC

phenylpropanolamine, combinations; oral

2.3

36.7

373

1739

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

36.5

R75

ICPC

Sinusitis acute/chronic

3.5

35.8

174

514

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

13.7

35.8

E0000UV

ATC

1.7

35.6

1142

8038

D07AC01

ATC

betamethasone; topical

1.7

34.9

1041

7168

Z51.6

ICD-10 Finland

Desensitization to allergens

11.0

34.9

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.8

34.8

153

416

A01AB04

ATC

amphotericin B; local oral

3.3

34.3

178

553

R01AD

ATC

Corticosteroids

7.7

34.2

108

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

5.0

33.5

111

229

R06AX12

ATC

terfenadine; oral

3.3

33.0

175

553

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.8

32.8

112

239

50509

ICD-8 Finland

Nasal polyp, Unspecified

117.9

32.7

M05BA04

ATC

alendronic acid; oral

2.6

32.4

259

1063

M79.6

ICD-10 Finland

Pain in limb

1.6

32.3

1037

7251

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

32.1

1005

6975

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

5.9

32.0

161

R4110

NOMESCO Finland

Physiotherapy

1.7

31.7

809

5300

SPAT1325

SPAT

Vaccination

1.6

31.6

991

6874

ZXC60

NOMESCO Finland

Application of heat

5.3

31.3

190

A03

ICPC

Fever

2.0

31.3

451

2435

50501

ICD-8 Finland

Nasal polyp, Maxillaris

60.6

31.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

33.7

30.9

T78.4

ICD-10 Finland

Allergy, unspecified

3.4

30.8

155

470

UJF32

NOMESCO Finland

Coloscopy

1.7

30.6

779

5092

L20.0

ICD-10 Finland

Besnier prurigo

2.9

30.6

196

704

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.1

30.4

172

568

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

30.1

635

3915

H02AB09

ATC

hydrocortisone; systemic

5.1

30.0

195

D07AC13

ATC

mometasone; topical

1.7

29.9

866

5863

R01BA01

ATC

phenylpropanolamine; oral

2.8

29.8

204

763

R08

ICPC

Nose symptom/complaint other

4.1

29.8

120

302

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.6

29.7

141

409

50499

ICD-8 Finland

Deflected nasal septum

5.3

29.5

178

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

8.5

29.4

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

15.7

29.4

3027

Kela drug reimbursment

Benralizumab

+∞

29.2

H65.0

ICD-10 Finland

Acute serous otitis media

7.1

29.1

103

J30.0

ICD-10 Finland

Vasomotor rhinitis

4.0

28.4

118

306

R03DX10

ATC

benralizumab; systemic

+∞

28.2

251

Kela drug reimbursment

+∞

28.2

ZXA05

NOMESCO Finland

Left side

1.7

27.9

759

5034

J32

ICD-10 Finland

Chronic sinusitis

11.5

27.8

R51.80

ICD-10 Finland

Headache

2.0

27.6

408

2219

ZXA00

NOMESCO Finland

Right side

1.6

27.5

816

5540

Z71.8

ICD-10 Finland

Other specified counselling

1.7

27.4

664

4256

I45.9

ICD-10 Finland

Conduction disorder, unspecified

12.4

27.2

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.5

26.8

225

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

26.7

514

3065

R81

ICPC

Pneumonia

3.5

26.5

127

372

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

26.3

425

2383

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

26.3

617

3913

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.8

26.3

189

R03CC02

ATC

salbutamol; systemic

3.2

26.3

145

472

R06.5

ICD-10 Finland

Mouth breathing

2.1

26.2

304

1496

R07

ICPC

Sneezing/nasal congestion

2.6

26.0

200

803

50708

ICD-8 Finland

Hay fever, Alia definita

12.2

26.0

4738X

ICD-9 Finland

Chronic sinusitis, Other chronic sinusitis

73.3

25.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

25.5

372

2010

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

7.2

25.3

DFF00

NOMESCO Finland

Pure tone audiometry

2.1

25.0

303

1518

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.5

24.1

117

346

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

23.9

149

527

DPB00

NOMESCO Finland

Partial excision of frontal sinus

67.9

23.8

R01AC02

ATC

levocabastine; nasal

3.7

23.4

105

292

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

23.3

268

1313

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

23.3

665

4436

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

23.2

323

1712

R06AX18

ATC

acrivastine; oral

3.6

23.1

108

311

4211

FHL

Transeptal septal resection and reconstruction

5.8

22.9

113

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.4

22.6

197

846

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

22.6

422

2484

R29

ICPC

Respiratory symptom/complaint other

2.4

22.5

195

836

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.3

22.5

118

371

R50.9

ICD-10 Finland

Fever, unspecified

1.8

22.5

408

2378

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

22.4

766

5345

M25.5

ICD-10 Finland

Pain in joint

1.6

22.2

771

5398

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

22.2

785

5520

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

22.1

2040

17510

S18

ICPC

Laceration/cut

1.5

21.6

1194

9251

DHB10

NOMESCO Finland

Excision of lesion of internal nose

10.4

21.6

SPAT1057

SPAT

Peak expiratory flow measurement

4.3

21.4

194

R03DA05

ATC

aminophylline; systemic, rectal

8.6

21.3

J02AC02

ATC

itraconazole; systemic

1.7

21.2

529

3392

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

21.0

500

3164

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

21.0

1113

8537

WZC30

NOMESCO Finland

Teaching

1.8

20.7

406

2421

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

5.9

20.7

100

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

20.6

780

5553

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

20.6

1590

13100

395

Kela drug reimbursment

Dupilumab

110.7

20.6

R01AX03

ATC

ipratropium bromide; nasal

3.8

20.3

228

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.5

19.9

279

ZX112

NOMESCO Finland

Subcutaneous

3.5

19.7

265

R01AC07

ATC

nedocromil; nasal

11.7

19.7

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

19.6

230

1135

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

19.3

1355

10917

J01FA01

ATC

erythromycin; systemic

1.8

19.1

368

2184

WX402

NOMESCO Finland

General anaesthesia

1.7

19.0

480

3081

E000002

ATC

1.9

18.9

310

1742

C07AB07

ATC

bisoprolol; oral

1.4

18.9

1312

10543

D07AB08

ATC

desonide; topical

1.9

18.8

295

1630

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

10.1

18.8

K02.1

ICD-10 Finland

Caries of dentine

1.4

18.8

1591

13240

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

18.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

18.5

215

1058

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

18.5

432

2714

L50.9

ICD-10 Finland

Urticaria, unspecified

3.1

18.4

105

350

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

18.2

1475

12148

L17

ICPC

Foot/toe symptom/complaint

1.5

18.2

673

4750

ZXC99

NOMESCO Finland

Other special technic in surgery

21.8

18.2

R03BB07

ATC

umeclidinium bromide; inhalant

10.4

18.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

18.0

1124

8826

R05FB02

ATC

cough suppressants and expectorants

1.4

18.0

1047

8120

H01

ICPC

Ear pain/earache

1.9

17.8

277

1528

51920

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis eosinophilica

95.6

17.6

D11AH05

ATC

dupilumab; topical

180.9

17.5

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

17.5

1231

9868

A01AB10

ATC

natamycin; local oral

3.2

17.5

292

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.9

17.3

107

379

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

17.3

453

2934

R49.01

ICD-10 Finland

Functional dysphonia

3.1

17.3

311

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

11.1

17.2

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

17.1

915

6964

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

16.9

742

5425

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

16.8

278

1565

M81.4

ICD-10 Finland

Drug-induced osteoporosis

12.1

16.8

A46

ICD-10 Finland

Erysipelas

1.7

16.8

383

2387

A02BA02

ATC

ranitidine; systemic

1.6

16.8

539

3674

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

16.7

653

4653

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

16.6

286

1633

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

16.6

1149

9159

GD1AA

SPAT

2.1

16.4

186

904

SPAT1255

SPAT

Intravenous administration of medicine

2.1

16.4

197

981

E000001

ATC

1.6

16.3

535

3660

R83

ICPC

Respiratory infection other

1.5

16.3

590

4134

P01AB01

ATC

metronidazole; oral, rectal

1.4

16.3

1080

8540

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

16.1

441

2883

N03AX16

ATC

pregabalin; oral

1.5

16.1

614

4350

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

16.1

195

975

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

16.1

1095

8691

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

16.1

268

1511

344

Kela drug reimbursment

Omalizumab

47.7

16.0

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

15.9

1606

13611

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

9.0

15.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

15.8

228

1222

4618A

ICD-9 Finland

Acute sinusitis, Other acute sinusitis

13.0

15.6

R49.08

ICD-10 Finland

Other specified dysphonia

3.5

15.6

207

D07AA02

ATC

hydrocortisone; topical

1.7

15.6

351

2176

R03

ICPC

Wheezing

6.0

15.4

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.2

15.3

157

732

SPAT1254

SPAT

Administration of medicine

1.7

15.3

365

2301

L50.8

ICD-10 Finland

Other urticaria

3.8

15.2

171

J98.1

ICD-10 Finland

Pulmonary collapse

8.7

15.2

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

6.5

15.2

R05CB01

ATC

acetylcysteine; inhalant, oral

4.1

15.2

147

N03AX12

ATC

gabapentin; oral

1.6

15.1

404

2624

R60.0

ICD-10 Finland

Localized oedema

1.8

15.1

295

1754

F2680

NOMESCO Finland

45.2

15.1

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

15.0

346

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

10.9

15.0

49099

ICD-8 Finland

Bronchitis, unspecified

5.4

14.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

14.9

249

1408

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

14.8

138

614

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

14.7

439

2931

C03CA01

ATC

furosemide; systemic

1.5

14.7

680

5006

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

14.6

424

2811

49309

ICD-8 Finland

Asthma, Unspecified

+∞

14.6

49308

ICD-8 Finland

Asthma, Alia definita

+∞

14.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

14.5

1974

17417

50709

ICD-8 Finland

Hay fever, Unspecified

5.9

14.5

L03

ICPC

Low back symptom/complaint

1.5

14.5

605

4359

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

14.4

1757

15228

WQ000

NOMESCO Finland

Hyposensibilisation

12.6

14.4

D07AD01

ATC

clobetasol; topical

1.6

14.3

426

2840

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

14.3

1023

8150

R04.2

ICD-10 Finland

Haemoptysis

2.7

14.1

354

SPAT1263

SPAT

Sampling

1.4

14.1

1142

9280

E000003

ATC

2.3

14.0

128

568

R01AD04

ATC

flunisolide; nasal

6.4

13.9

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

10.1

13.9

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

13.9

376

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.6

13.9

175

L04AX01

ATC

azathioprine; systemic

2.3

13.8

134

607

R53

ICD-10 Finland

Malaise and fatigue

1.5

13.8

503

3516

R03DB04

ATC

theophylline and adrenergics; systemic

17.6

13.8

R05CB02

ATC

bromhexine; systemic

4.1

13.8

131

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

7.1

13.8

N05BB01

ATC

hydroxyzine; systemic

2.0

13.7

169

852

Z01.7

ICD-10 Finland

Laboratory examination

1.7

13.7

291

1772

SPAT1036

SPAT

Maxillary puncture

10.5

13.7

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.1

13.7

149

715

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

13.6

298

1832

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

5.7

13.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

13.6

508

3570

DPB20

NOMESCO Finland

Obliteration of frontal sinus

+∞

13.5

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

13.5

253

1484

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

13.4

249

1453

1210

FHL

Anthroscopy

9.4

13.4

H66

ICD-10 Finland

Suppurative and unspecified otitis media

3.5

13.4

185

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

4.4

13.4

111

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

13.4

288

1760

DGW00

NOMESCO Finland

Dilatation of eustachian tube

12.9

13.4

M03BX02

ATC

tizanidine; oral

1.3

13.3

1730

15055

J01MA01

ATC

ofloxacin; systemic

1.8

13.3

243

1414

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

13.2

753

5751

WX290

NOMESCO Finland

Other blockade of nerve

1.3

13.2

1166

9577

K11.2

ICD-10 Finland

Sialoadenitis

2.6

13.0

360

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

13.0

420

2855

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

16.8

13.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

12.9

315

1997

R03DX05

ATC

omalizumab; parenteral

50.2

12.8

R21

ICPC

Throat symptom/complaint

1.5

12.8

444

3064

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

4.0

12.8

126

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.3

12.8

198

M54.5

ICD-10 Finland

Low back pain

1.4

12.8

842

6591

Z2446

NOMESCO Finland

Social worker

2.0

12.8

170

885

D02AE01

ATC

carbamide; topical

1.9

12.8

180

957

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

12.7

567

4129

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

12.7

469

3286

R95

ICPC

Chron obstructive pulmonary disease

3.0

12.6

242

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

12.6

377

2514

KMAK

NOMESCO Finland

1.3

12.6

1415

12018

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

12.5

289

1800

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

12.5

190

1037

R03CC03

ATC

terbutaline; systemic

3.7

12.5

144

XQ802

NOMESCO Finland

Epicutan test

2.3

12.5

110

480

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.9

12.5

XG460

NOMESCO Finland

Short time oxymetry

3.7

12.4

145

R42

ICD-10 Finland

Dizziness and giddiness

1.5

12.4

539

3905

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

12.3

607

4509

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

12.2

587

4336

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

9.7

12.2

DM1CI

NOMESCO Finland

Very extensive cone beam CT of paranasal sinus

18.1

12.0

L50.0

ICD-10 Finland

Allergic urticaria

2.9

12.0

253

L50.3

ICD-10 Finland

Dermatographic urticaria

3.8

12.0

129

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

12.0

246

1484

48609

ICD-8 Finland

Pneumonia, unspecified

3.7

11.9

140

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

11.8

169

904

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

11.8

274

1711

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.2

11.7

184

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.4

11.7

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

65.2

11.6

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.1

11.5

209

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.4

11.5

406

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

11.4

241

1463

C08DA01

ATC

verapamil; systemic

2.2

11.4

115

532

3DX05

NOMESCO Finland

120.4

11.4

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.2

11.4

101

ZX120

NOMESCO Finland

Intravenous

1.7

11.3

250

1542

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

15.1

11.3

A98

ICPC

Health maint/preventive medicine

1.6

11.2

2968

28454

XQ820

NOMESCO Finland

Exposure to medicinal substance

10.6

11.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

11.2

337

2247

H26.3

ICD-10 Finland

Drug-induced cataract

6.6

11.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

11.2

335

2236

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

11.2

782

6159

R07.0

ICD-10 Finland

Pain in throat

2.0

11.1

147

764

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.9

11.1

237

R2110

NOMESCO Finland

Giving the first information

1.8

11.0

182

1026

D01BA02

ATC

terbinafine; oral; topical

1.4

11.0

681

5249

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.0

11.0

142

732

N05CF01

ATC

zopiclone; oral

1.3

11.0

830

6613

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.9

10.8

111

R52.9

ICD-10 Finland

Pain, unspecified

1.7

10.8

203

1195

R06AX11

ATC

astemizole; oral

2.5

10.8

327

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.1

10.8

191

M54.2

ICD-10 Finland

Cervicalgia

1.8

10.7

179

1011

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

10.7

723

5658

R13

ICD-10 Finland

Dysphagia

1.9

10.7

167

923

R06AE08

ATC

4.8

10.7

X58

ICD-10 Finland

Exposure to other specified factors

1.5

10.6

342

2318

R78

ICPC

Acute bronchitis/bronchiolitis

2.8

10.6

236

C09CA06

ATC

candesartan; oral

1.4

10.6

557

4171

4225

FHL

Exploratory buccal opening, includes polyps and cyst removal

8.0

10.6

XG466

NOMESCO Finland

Sleep oxymetry

2.3

10.5

414

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

10.5

864

6961

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

9.2

10.5

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

10.5

240

1494

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

10.4

448

3231

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

10.4

292

1915

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

10.4

366

2535

R50

ICPC

Respiratory, Medication/prescr/renewal

12.1

10.3

K30

ICD-10 Finland

Functional dyspepsia

1.6

10.3

248

1564

J01MA06

ATC

norfloxacin; oral

1.5

10.3

328

2217

A02BC04

ATC

rabeprazole; oral

1.7

10.3

217

1319

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

10.3

228

1405

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

10.2

324

2191

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

10.2

372

2594

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.7

10.2

118

B01AC04

ATC

clopidogrel; oral

1.5

10.1

396

2802

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

10.1

168

950

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

10.1

556

4196

J05AB01

ATC

aciclovir; systemic

1.4

10.0

508

3776

G50.1

ICD-10 Finland

Atypical facial pain

3.1

10.0

179

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

10.0

128

661

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

40.2

10.0

ZXB87

NOMESCO Finland

Balloon dilation, paranasal sinuses

40.2

10.0

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.0

1567

13760

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

10.0

142

762

G04CA02

ATC

tamsulosin; oral

1.4

9.9

621

4789

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

9.9

198

1187

WW200

NOMESCO Finland

Immunization

2.4

9.9

353

R03BA07

ATC

mometasone; inhalant

4.9

9.9

L16

ICPC

Ankle symptom/complaint

1.6

9.9

234

1473

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.4

9.8

137

DM1BI

NOMESCO Finland

Extensive cone beam CT of paranasal sinus

26.1

9.8

S01GX02

ATC

levocabastine; ophthalmic

1.9

9.7

142

766

N06AX21

ATC

duloxetine; oral

1.6

9.7

256

1651

U02

ICPC

Urinary frequency/urgency

1.5

9.7

301

2021

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

9.7

394

2807

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

9.6

450

3295

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.8

9.6

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

9.6

195

1173

A03FA02

ATC

cisapride; oral, rectal

1.7

9.5

191

1145

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

9.5

172

1000

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

9.4

688

5435

R35

ICD-10 Finland

Polyuria

1.8

9.4

167

966

S21

ICPC

Skin texture symptom/complaint

1.5

9.3

302

2050

H70.1

ICD-10 Finland

Chronic mastoiditis

6.9

9.3

N06AB04

ATC

citalopram; systemic

1.4

9.3

523

3962

WZA90

NOMESCO Finland

Other doctors statement

1.4

9.2

576

4435

M48.0

ICD-10 Finland

Spinal stenosis

1.5

9.2

285

1914

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.8

9.1

R07.3

ICD-10 Finland

Other chest pain

1.6

9.1

228

1453

J01DC04

ATC

cefaclor; oral

3.5

9.1

119

R04.0

ICD-10 Finland

Epistaxis

1.7

9.1

179

1068

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

9.1

1214

10401

D09AB01

ATC

zinc bandage without supplements; topical

2.7

9.0

215

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

9.0

193

1179

M54

ICD-10 Finland

Dorsalgia

1.6

9.0

257

1695

ZXD05

NOMESCO Finland

Urgent procedure

1.3

9.0

790

6410

F2682

NOMESCO Finland

24.1

8.9

SPAT1260

SPAT

Consultation of another employee

1.4

8.9

448

3323

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

8.9

588

4567

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

8.9

379

2725

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.5

8.8

261

J01X

ATC

OTHER ANTIBACTERIALS

4.8

8.8

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

8.8

169

998

L01

ICPC

Neck symptom/complaint

1.5

8.8

312

2160

4212

FHL

Maxillapremmaxilla opening septum resection and reconstruction

4.9

8.8

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

8.8

287

1954

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

8.7

2368

25181

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

8.7

266

1780

L29.9

ICD-10 Finland

Pruritus, unspecified

2.6

8.7

249

K51.5

ICD-10 Finland

Left sided colitis

2.3

8.7

333

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

8.7

190

1170

E000007

ATC

1.8

8.7

134

742

4718X

ICD-9 Finland

Nasal polyps, Other polyp of sinus

50.1

8.7

4710A

ICD-9 Finland

Nasal polyps, Polyp of nasal cavity

50.1

8.7

L04AA06

ATC

mycophenolic acid; systemic

2.8

8.6

186

L30.3

ICD-10 Finland

Infective dermatitis

2.1

8.6

422

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

7.6

8.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

8.6

592

4627

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.3

8.5

350

N01

ICPC

Headache

1.6

8.5

206

1303

B37.0

ICD-10 Finland

Candidal stomatitis

4.4

8.5

J01CA02

ATC

pivampicillin; oral

2.2

8.5

384

K07

ICPC

Swollen ankles/oedema

2.0

8.5

492

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

8.5

315

2201

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

20.1

8.5

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

20.1

8.5

B01AB05

ATC

enoxaparin; parenteral

1.3

8.5

780

6362

E000006

ATC

1.7

8.5

169

1013

B01AA03

ATC

warfarin; systemic

1.4

8.4

479

3630

4720A

ICD-9 Finland

Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS CHRONICA HYPERTROPHICA]

12.8

8.4

G04CA01

ATC

alfuzosin; oral

1.5

8.3

312

2186

SPAT1310

SPAT

Counselling related to known health issue

1.3

8.3

795

6511

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.3

717

5791

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

2.9

8.3

173

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

8.3

188

1170

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

10.8

8.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

8.3

457

J31.1

ICD-10 Finland

Chronic nasopharyngitis

4.4

8.2

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

8.2

414

3073

D11

ICPC

Diarrhoea

1.5

8.1

248

1662

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

4.1

8.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

8.1

200

1273

XG420

NOMESCO Finland

Time-volume spirometry

33.4

8.1

DHB30

NOMESCO Finland

Polypectomy of choana through maxillary antrum

33.4

8.1

DNW99

NOMESCO Finland

Other operation on ethmoidal sinus and bone

17.2

8.1

C05AA08

ATC

fluocortolone; rectal, topical

1.4

8.0

364

2645

R11

ICD-10 Finland

Nausea and vomiting

1.7

8.0

177

1094

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.3

8.0

116

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.0

8.0

G44.2

ICD-10 Finland

Tension-type headache

1.5

8.0

298

2084

XKD00

NOMESCO Finland

Uroflowmetry

1.4

8.0

420

3139

A91

ICPC

Abnormal result investigation NOS

1.9

8.0

104

542

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.4

8.0

284

J05AB11

ATC

valaciclovir; oral

1.5

7.9

305

2151

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.4

7.9

107

U13

ICPC

Bladder symptom/complaint other

2.2

7.9

338

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

7.8

253

1719

RK110

NOMESCO Finland

4.7

7.8

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

7.8

187

1181

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

7.8

168

1034

R01AC03

ATC

azelastine; nasal

9.4

7.8

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.5

7.8

224

1482

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

7.7

138

799

J01GB01

ATC

tobramycin; inhalant, parenteral

45.1

7.7

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.6

7.7

180

1129

L15

ICPC

Knee symptom/complaint

1.3

7.7

489

3772

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

7.7

298

2102

A11

ICPC

Chest pain NOS

1.6

7.6

178

1118

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

7.6

209

1365

S02

ICPC

Pruritus

2.2

7.6

342

N06AX16

ATC

venlafaxine; oral

1.4

7.6

307

2183

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

7.6

230

1541

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

7.6

323

2321

ZFX00

NOMESCO Finland

Use of balloon dilatation

18.4

7.6

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

7.6

283

1983

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

7.6

658

5308

EB1AA

SPAT

1.8

7.6

115

635

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

7.6

356

DNB30

NOMESCO Finland

Excision of lesion of ethmoidal sinus

25.1

7.6

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

7.5

268

1861

DC1AD

NOMESCO Finland

Temporalbone CT

3.2

7.5

117

48509

ICD-8 Finland

Bronchopneumonia, unspecified

3.1

7.5

123

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.5

684

5560

XX9XW

NOMESCO Finland

4.0

7.4

M79.1

ICD-10 Finland

Myalgia

1.5

7.4

288

2034

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.4

1088

9369

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

7.4

299

2129

4223

FHL

Outeroid etomoidectomy

80.3

7.4

K90.0

ICD-10 Finland

Coeliac disease

2.2

7.4

332

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

7.4

144

860

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

7.4

521

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

7.4

494

K07.60

ICD-10 Finland

Snapping jaw

1.9

7.3

524

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

7.3

586

4673

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

7.3

553

4374

4230

FHL

Forehead cavity radical cutting and filling

+∞

7.3

I42.3

ICD-10 Finland

Endomyocardial (eosinophilic) disease

+∞

7.3

49330

ICD-8 Finland

+∞

7.3

49310

ICD-8 Finland

+∞

7.3

J01XB01

ATC

colistin; inhalant, parenteral

+∞

7.3

3DX08

NOMESCO Finland

+∞

7.3

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

7.3

125

716

R05CA10

ATC

expectorants - combinations

2.5

7.3

208

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.9

7.3

137

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.5

7.3

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

7.2

184

D01AC02

ATC

miconazole; topical

1.6

7.2

194

1263

J01.3

ICD-10 Finland

Acute sphenoidal sinusitis

15.8

7.2

120

Kela drug reimbursment

Hypogammaglobulinaemia

15.8

7.2

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

7.2

378

K80

ICPC

Cardiac arrhythmia NOS

1.6

7.2

173

1094

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

7.2

150

913

J01AA04

ATC

lymecycline; systemic

1.4

7.1

305

2195

50306

ICD-8 Finland

Chronic sinusitis, Pansinuitis chronica

30.1

7.1

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.7

7.1

155

955

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

7.1

341

2506

T78.3

ICD-10 Finland

Angioneurotic oedema

2.9

7.1

142

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

20.1

7.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.1

256

1782

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

6.6

7.1

DM1QA

SPAT

2.7

7.1

173

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

7.1

924

7839

A99

ICPC

Disease/condition unspecnature/site

1.6

7.1

180

1156

-1

NOMESCO Finland

1.3

7.1

823

6890

L05

ICPC

Flank/axilla symptom/complaint

1.8

7.1

125

724

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

7.1

636

5154

S97

ICPC

Chronic ulcer skin

1.8

7.1

125

726

N17

ICPC

Vertigo/dizziness

1.5

7.0

245

1689

R49.09

ICD-10 Finland

Unspecified dysphonia

3.6

7.0

DMA00

NOMESCO Finland

Biopsy of maxillary antrum

8.8

7.0

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.5

7.0

218

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

7.0

104

570

S29

ICPC

Skin symptom/complaint other

1.4

7.0

391

2950

4781C

ICD-9 Finland

Other diseases of upper respiratory tract, Other diseases of nasal cavity and sinuses[CYSTA SINUS MAXILLARIS]

7.0

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

7.0

257

1793

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

7.0

498

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

2.3

7.0

277

WX722

NOMESCO Finland

PEEP

1.8

7.0

119

684

D02AX

ATC

Other emollients and protectives

2.1

7.0

356

S22.3

ICD-10 Finland

Fracture of rib

1.6

7.0

155

964

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

7.0

514

C08DB01

ATC

diltiazem; oral

1.8

6.9

122

705

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

6.9

143

870

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.1

6.9

338

R43.0

ICD-10 Finland

Anosmia

3.9

6.9

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.9

6.9

R48

ICPC

Respiratory, Clarification/discussion RFE/demand

4.8

6.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

6.8

188

1231

Y0499

ICD-8 Finland

Investigation of respiratory system

3.4

6.8

WX320

NOMESCO Finland

Spinalanesthesy

1.3

6.8

560

4479

S01GX08

ATC

ketotifen; ophthalmic

2.0

6.8

391

D19

ICPC

Teeth/gum symptom/complaint

1.3

6.7

630

5127

DM1CG

NOMESCO Finland

Paranasal sinuses and face area extensive MRI examination with high intensity magnet

16.7

6.7

L28

ICPC

Limited function/disability (L)

1.4

6.7

341

2534

50700

ICD-8 Finland

22.6

6.7

M05BA07

ATC

risedronic acid; oral

2.1

6.7

350

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

6.6

250

1754

R03AC18

ATC

indacaterol; inhalant

4.4

6.6

L12

ICPC

Hand/finger symptom/complaint

1.4

6.6

314

2302

XA420

NOMESCO Finland

Extensive sleep examination

2.9

6.6

123

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

6.6

101

560

R97

ICPC

Allergic rhinitis

2.8

6.6

146

A92

ICPC

Allergy/allergic reaction NOS

2.4

6.6

224

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

6.6

205

1382

R03AC19

ATC

olodaterol; inhalant

5.9

6.6

R10.0

ICD-10 Finland

Acute abdomen

2.1

6.6

354

GX1E5

SPAT

12.3

6.6

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.6

293

2125

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.7

6.6

N06AX11

ATC

mirtazapine; oral

1.3

6.5

758

6334

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

6.5

339

2528

J04.0

ICD-10 Finland

Acute laryngitis

2.2

6.5

278

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

6.5

261

1855

ZY010

NOMESCO Finland

Hospital outpatient

1.8

6.5

102

572

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

6.5

109

623

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

6.5

312

2298

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.3

6.5

239

S02.51

ICD-10 Finland

Fracture of tooth, open

1.5

6.5

242

1697

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

6.5

135

825

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

6.5

242

1698

L95

ICPC

Osteoporosis

2.1

6.4

315

H60.3

ICD-10 Finland

Other infective otitis externa

2.3

6.4

249

R04

ICPC

Breathing problem other

2.0

6.4

391

4733A

ICD-9 Finland

Chronic sinusitis, Sphenoidal

70.0

6.4

4231

FHL

Sphenotomy

70.0

6.4

H10

ICD-10 Finland

Conjunctivitis

1.7

6.4

128

772

I45.0

ICD-10 Finland

Right fascicular block

4.3

6.4

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

6.4

406

DFF15

NOMESCO Finland

Speech audiometry

1.7

6.4

112

650

J01.8

ICD-10 Finland

Other acute sinusitis

4.7

6.4

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

4.1

6.4

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

2.0

6.4

380

R4130

NOMESCO Finland

Speech therapy

2.3

6.4

243

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

6.4

248

1755

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.3

6.3

224

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.1

6.3

332

L50.1

ICD-10 Finland

Idiopathic urticaria

4.4

6.3

S51.8

ICD-10 Finland

Open wound of other parts of forearm

3.3

6.3

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.3

524

4193

XF402

NOMESCO Finland

ECG with work load test

1.4

6.3

276

1994

L20

ICD-10 Finland

Atopic dermatitis

2.3

6.3

236

H93.1

ICD-10 Finland

Tinnitus

1.6

6.3

153

974

DMW00

NOMESCO Finland

Intubation of maxillary antrum

5.9

6.3

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

2.4

6.3

199

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

6.3

489

3880

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.5

6.3

170

50303

ICD-8 Finland

Chronic sinusitis, Frontalis NUD

18.0

6.3

F1246

NOMESCO Finland

18.0

6.3

DMB30

NOMESCO Finland

Transmaxillary excision of lesion of maxillary antrum

18.0

6.3

P06

ICPC

Sleep disturbance

1.5

6.3

217

1500

DPB10

NOMESCO Finland

Partial excision of sphenoidal sinus

+∞

6.2

49320

ICD-8 Finland

+∞

6.2

4AC06

NOMESCO Finland

+∞

6.2

UKC02

NOMESCO Finland

Cystoscopy

1.3

6.2

396

3051

DCW00

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

26.7

6.2

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

26.7

6.2

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

26.7

6.2

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

26.7

6.2

50308

ICD-8 Finland

Chronic sinusitis, Alia definita

26.7

6.2

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.2

625

5131

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

7.0

6.2

H02.6

ICD-10 Finland

Xanthelasma of eyelid

7.0

6.2

RK320

NOMESCO Finland

3.4

6.2

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.2

187

1254

L12.0

ICD-10 Finland

Bullous pemphigoid

4.1

6.2

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.3

6.2

241

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.0

6.2

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

6.2

140

874

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

6.1

545

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

6.1

115

681

4451

FHL

Guitar cutting

2.4

6.1

213

E66.8

ICD-10 Finland

Other obesity

1.8

6.1

106

613

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

6.1

151

963

A13

ICPC

Concern/fear medical treatment

2.7

6.1

152

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

6.1

218

1514

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.9

6.1

430

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

6.1

226

1582

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

6.1

331

2490

D01

ICPC

Abdominal pain/cramps general

1.5

6.1

223

1558

S16

ICPC

Bruise/contusion

2.0

6.1

352

4122

FHL

Tympanostomy (tympanic tube)

3.3

6.1

4227

FHL

Forehead cavity drainage

8.6

6.0

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

6.0

197

1344

H92.0

ICD-10 Finland

Otalgia

1.7

6.0

107

625

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

6.0

527

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.1

6.0

318

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

266

37.16

307.65

1.6

1.2

u/ml

2.0

0.1

2.96

181

(4010399)

796

1696

5.71

307.65

1.8

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

1019

1301

10.45

307.65

2.1

1.1

u/ml

414.1

206.9

2.67

998

1168

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

327

361

9.85

272.33

1.3

1.1

u/ml

0.7

1.1

0.80

213

116

(3000492) Spirometry study

855

2420

4.30

272.28

1.9

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

303

317

10.33

262.38

1.2

1.0

u/ml

2.6

5.8

1.83

218

140

(3010726) Horse dander IgE Ab [Units/volume] in Serum

283

271

11.23

260.76

1.2

1.0

u/ml

1.0

1.5

0.42

119

(3008401) Mugwort IgE Ab [Units/volume] in Serum

279

311

9.63

230.12

1.2

1.0

u/ml

0.6

1.5

0.98

189

114

(3013115) Eosinophils [#/volume] in Blood

2508

15041

3.10

221.73

8.0

5.9

e9/l

0.3

0.2

129.43

2250

13154

(3006315) Basophils [#/volume] in Blood

2407

14561

2.89

200.77

7.7

5.7

e9/l

0.0

28.45

2127

12544

(3001604) Monocytes [#/volume] in Blood

2399

14492

2.89

200.56

7.6

5.7

e9/l

0.6

11.22

2121

12483

(3019198) Lymphocytes [#/volume] in Blood

2433

14926

2.86

195.23

7.7

5.8

e9/l

1.9

0.31

2187

13099

(3007853) Bacteria identified in Skin by Aerobe culture

912

3347

3.29

191.14

2.3

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

472

1192

4.40

170.42

1.6

1.5

u/ml

15.0

20.2

—

(3022096) Basophils/100 leukocytes in Blood

2185

13251

2.60

169.60

7.8

6.0

0.7

5.48

2096

12320

(3019069) Monocytes/100 leukocytes in Blood

2235

13723

2.60

168.65

8.0

6.2

8.4

8.7

6.14

2147

12811

(3006504) Eosinophils/100 leukocytes in Blood

2226

13649

2.60

168.34

7.8

6.0

4.7

2.8

87.80

2134

12672

(3013650) Neutrophils [#/volume] in Blood by Automated count

2572

17030

2.70

163.74

9.9

9.1

e9/l

4.3

4.1

6.78

2278

14805

(42870588) Differential panel, method unspecified - Blood

1779

9923

2.54

162.94

7.0

5.8

—

(3018010) Neutrophils/100 leukocytes in Blood

2236

13879

2.56

162.49

7.7

5.8

57.1

57.2

0.20

2149

12931

(3002030) Lymphocytes/100 leukocytes in Blood

2258

14103

2.56

161.54

7.9

6.0

26.2

27.9

12.98

2160

13077

(3023430) Cat dander IgE Ab [Units/volume] in Serum

198

226

9.20

159.76

1.2

1.0

u/ml

3.4

3.5

0.04

131

(3014133) Dog dander IgE Ab [Units/volume] in Serum

204

249

8.62

156.08

1.2

1.0

u/ml

4.0

2.1

0.84

137

(3023419) Bacteria identified in Sputum by Culture

205

264

8.16

150.02

3.6

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

385

949

4.41

142.64

1.9

1.6

titre

166.2

431.0

1.22

(3027135) IgG subclass 1 [Mass/volume] in Serum

188

237

8.31

139.96

1.9

1.3

g/l

6.1

6.9

1.86

147

161

(3024139) IgG subclass 3 [Mass/volume] in Serum

188

237

8.31

139.96

1.9

1.3

g/l

0.3

0.4

3.46

146

160

(3028192) IgG subclass 2 [Mass/volume] in Serum

188

237

8.31

139.96

1.9

1.3

g/l

3.0

2.9

0.13

145

160

(4062490)

186

239

8.14

136.26

1.9

1.3

—

(3042936) Bacteria identified in Isolate by Culture

928

4107

2.69

133.04

2.2

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

231

408

5.97

125.67

2.0

1.6

g/l

1.2

0.8

2.51

182

308

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

168

214

8.18

123.88

1.2

1.0

u/ml

0.3

0.5

0.35

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

27.43

102.76

1.4

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

206

432

4.99

92.45

1.7

1.4

—

(3000494) Fungus identified in Specimen by Culture

742

3459

2.43

91.66

1.9

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2832

22084

2.23

89.59

5.4

3.9

mm/h

12.7

12.0

1.54

2687

20403

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

275

769

3.78

84.72

2.0

1.3

iu/ml

15.5

12.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

142

231

6.35

83.69

4.4

3.5

—

(3021589) Normoblasts [#/volume] in Blood

1897

13087

1.93

80.93

10.8

9.3

e9/l

0.0

1.01

1516

10716

(40768804) Tissue Pathology biopsy report

1767

12262

1.85

70.54

2.2

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

639

3103

2.28

70.21

1.9

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

493

2157

2.48

68.51

3.0

2.7

g/l

10.0

10.7

3.40

467

1948

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

634

3114

2.25

67.57

1.8

1.7

—

(40758558) Short blood count panel - Blood

1200

7448

1.91

67.37

7.4

6.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

823

4582

2.03

62.86

2.0

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

265

885

3.15

61.49

3.0

2.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1020

6227

1.88

58.78

1.8

1.7

mg/l

1.0

1.3

2.13

780

4786

(3036481) Cortisol [Moles/volume] in Serum or Plasma

530

2556

2.25

58.44

2.7

2.1

nmol/l

295.0

379.3

22.15

494

2339

(4015189)

11.74

57.65

2.9

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

393

1692

2.48

56.03

1.9

g/l

1.2

1.4

0.84

368

1527

(3023368) Bacteria identified in Blood by Culture

1223

8026

1.79

54.96

4.7

4.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3384

30133

2.55

53.23

19.8

13.7

mg/l

23.8

24.4

0.44

2921

23670

(44813793)

147

6.18

51.62

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

881

5386

1.84

49.19

1.6

1.5

g/l

2.5

0.12

569

3263

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

14.99

48.53

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2780

23334

1.79

48.00

8.4

7.6

u/l

76.0

78.4

1.59

2650

21975

(40760892) CBC W Ordered Manual Differential panel - Blood

995

6375

1.77

47.17

5.8

4.4

—

(3018418) pH of Serum or Plasma

1268

8698

1.70

46.99

4.0

4.2

7.4

0.07

193

1670

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1929

14830

1.63

45.17

6.8

6.9

mmol/l

1.2

1.54

1693

12535

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1771

13462

1.61

42.41

6.0

mmol/l

1.2

0.36

1627

12197

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

167

541

3.19

40.63

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

167

541

3.19

40.63

1.4

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1593

11987

1.58

38.55

2.5

2.2

nmol/l

78.3

77.7

0.40

1474

10741

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.83

38.41

1.1

u/ml

2.7

2.3

0.05

(3013826) Glucose [Moles/volume] in Serum or Plasma

2187

17709

1.58

38.33

5.2

4.7

mmol/l

6.6

6.7

1.78

2081

16602

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

209

793

2.73

38.28

1.5

1.6

g/l

0.2

0.18

203

749

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1187

8352

1.62

37.97

3.2

2.9

ng/l

1201.6

1453.0

1.28

1032

7138

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2217

18039

1.58

37.78

3.3

2.7

—

(3002385) Erythrocyte distribution width [Ratio]

2869

24861

1.70

37.67

22.7

16.8

13.8

13.7

4.72

2833

24300

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1970

15643

1.56

37.07

6.2

6.3

umol/l

10.8

11.6

2.96

1874

14852

(3037522) Nuclear Ab [Titer] in Serum

639

3832

1.81

36.79

1.4

1.3

titre

440.0

541.1

0.67

109

824

(40768797) Stomach Pathology biopsy report

666

4060

1.78

36.23

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

195

737

2.74

35.98

2.1

1.9

mg/l

10.7

11.6

0.85

184

678

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

210

828

2.63

35.64

1.5

1.6

g/l

1.2

0.85

204

784

(3024561) Albumin [Mass/volume] in Serum or Plasma

1675

12920

1.54

35.26

4.9

g/l

35.3

35.5

1.03

1568

12041

(3031040) Bacteria [#/volume] in Urine by Automated count

2336

19396

1.56

35.06

4.7

4.3

e6/l

304.4

1970.1

2.16

276

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

185

691

2.77

34.91

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

167

606

2.84

33.27

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

266

1209

2.29

33.11

2.1

1.8

u/l

36.5

38.9

1.18

245

1050

(3019420) Tryptase [Mass/volume] in Serum or Plasma

130

5.23

32.83

1.4

1.7

ug/l

8.7

10.3

0.28

114

(3044889) 12 lead EKG panel

2516

21435

1.55

31.96

4.3

3.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

856

5762

1.63

31.77

4.1

3.6

ng/l

352.4

636.7

0.82

667

4527

(3018095) Leukocytes [#/volume] in Urine

1390

10467

1.53

31.62

4.1

3.6

e6/l

51.7

105.3

3.39

987

7423

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1583

12275

1.51

31.21

2.1

2.0

pmol/l

95.0

95.6

0.20

819

6392

(36304419) Bacteria [Presence] in Urine

1115

8021

1.56

31.13

3.4

3.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3394

31338

2.09

31.10

20.3

15.9

mmol/l

139.7

0.11

3334

30562

(3030467) Casts [#/volume] in Urine by Automated count

1136

8214

1.55

30.97

3.5

3.1

e6/l

0.3

0.4

4.31

841

6179

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1582

12294

1.50

30.70

3.1

2.7

ug/l

113.9

141.5

6.16

1472

11340

(3023103) Potassium [Moles/volume] in Serum or Plasma

3400

31450

2.08

30.42

20.5

16.0

mmol/l

3.9

4.0

16.82

3336

30620

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

21.03

30.30

1.7

1.8

mg/l

1.4

3.7

—

(3033658) Prothrombin time (PT) actual/Normal

1067

7657

1.55

29.87

4.0

3.9

92.1

89.2

3.47

1046

7482

(3002582) Erythrocytes [#/volume] in Urine

1218

9002

1.53

29.78

3.5

3.2

e6/l

48.7

104.8

1.49

919

6907

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

6.14

29.70

1.2

1.1

u/ml

4.4

6.9

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

22.13

29.56

1.7

1.8

mg/l

1.7

1.9

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

22.13

29.56

1.7

1.8

mg/l

1.2

0.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

22.13

29.56

1.7

1.8

mg/l

1.0

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

50.44

29.36

1.6

1.9

umol/l

55.2

33.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2400

20459

1.50

28.48

4.8

4.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

347

3.24

28.00

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

727

4842

1.63

27.68

1.3

iu/ml

32.4

32.5

0.01

231

1519

(3021440) Promyelocytes/100 leukocytes in Blood

412

2348

1.85

27.49

4.4

4.2

0.1

0.23

120

666

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2607

22694

1.51

27.20

4.3

3.8

pmol/l

14.9

14.8

1.21

2415

20611

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

134

485

2.83

26.85

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

109

351

3.17

26.83

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

696

4619

1.63

26.80

1.3

1.2

u/ml

13.2

12.2

0.13

251

1774

(3042631) Mycobacterium sp identified in Specimen

109

352

3.16

26.70

3.4

2.5

—

(3017181) Myelocytes/100 leukocytes in Blood

424

2466

1.81

26.44

4.4

4.1

0.8

0.9

0.17

121

718

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

108

349

3.16

26.43

1.1

—

(3025159) Blasts/100 leukocytes in Blood

387

2191

1.86

26.33

4.5

4.2

0.0

0.2

0.76

101

550

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

164

666

2.53

26.19

1.2

1.1

—

(3022145) Colonoscopy Study observation

529

3306

1.70

25.62

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

392

2249

1.83

25.53

4.0

3.9

0.5

0.6

0.77

508

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1003

7321

1.51

25.13

2.4

2.2

mg/l

3.0

2.9

0.07

857

6238

(3014599) Egg white IgE Ab [Units/volume] in Serum

107

5.01

24.87

1.0

u/ml

4.1

0.4

0.67

(3003327) Ova and parasites identified in Stool by Light microscopy

193

869

2.29

24.51

1.9

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3148

28789

1.65

24.47

16.4

13.0

ml/min/173m2

81.7

80.3

3.42

2674

23743

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

105

5.01

24.40

4.8

3.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3029

27476

1.58

23.99

5.2

4.6

mu/l

1.9

2.1

0.92

2826

25089

(3000850) Epithelial cells [#/volume] in Urine

870

6219

1.52

23.88

2.8

2.6

e6/l

4.5

5.3

1.21

752

5467

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1431

11306

1.44

23.49

4.1

3.5

ng/l

29.1

96.8

1.01

1016

7821

(3027801) Oxygen [Partial pressure] in Arterial blood

523

3350

1.65

22.89

6.6

7.7

kpa

11.7

12.5

2.70

493

3200

(3015377) Calcium [Moles/volume] in Serum or Plasma

1286

10003

1.44

22.80

3.3

3.4

mmol/l

2.3

2.4

2.74

1150

8721

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1186

9091

1.45

22.74

2.3

2.1

u/l

144.8

230.0

4.75

1113

8533

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

522

3351

1.65

22.63

6.6

7.7

kpa

5.0

5.1

0.52

492

3200

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3439

32373

1.97

22.60

21.0

16.2

umol/l

77.3

78.8

2.19

3439

32362

(3015076) Soybean IgE Ab [Units/volume] in Serum

5.11

22.58

1.0

u/ml

0.3

—

(40761511) CBC panel - Blood by Automated count

3368

31508

1.83

22.39

16.0

13.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

160

691

2.38

22.38

1.3

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

108

386

2.85

22.19

1.4

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

673

4616

1.56

22.10

2.3

2.6

umol/l

43.3

13.2

0.48

619

4298

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

184

3.75

21.96

1.9

2.7

e9/l

0.3

0.2

1.18

164

(3020874) Milk IgE Ab [Units/volume] in Serum

111

4.65

21.93

1.0

u/ml

0.7

1.2

0.28

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

847

6114

1.50

21.91

1.3

1.2

u/ml

2.2

1.8

0.22

204

1610

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

237

3.38

21.85

1.2

titre

159.4

118.9

0.22

(3003396) Base excess in Arterial blood by calculation

516

3346

1.63

21.42

6.7

7.7

mmol/l

1.3

0.9

1.50

387

2610

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

306

1717

1.85

21.30

1.7

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

520

3389

1.62

21.13

2.5

2.2

ug/g

121.4

138.1

0.71

436

2673

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

6.15

21.09

1.1

u/ml

2.3

4.0

—

(3000060) B lymphocytes [#/volume] in Blood

5.81

21.01

1.6

2.3

e6/l

244.0

169.3

0.64

(3008536) Aspergillus sp Ab [Presence] in Serum

6.65

20.84

1.5

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

715

5036

1.52

20.65

3.0

2.7

e6/l

0.7

1.1

4.77

398

2839

(3011397) Hemoglobin [Presence] in Urine by Test strip

911

6750

1.46

20.47

3.7

3.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

677

4721

1.53

20.47

3.1

2.9

e6/l

1.9

2.3

0.76

360

2550

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

591

4004

1.57

20.33

2.4

2.6

22.1

23.3

1.17

507

3458

(3021601) Nitrite [Presence] in Urine by Test strip

1729

14377

1.38

20.02

5.2

4.8

estimate

0.0

0.80

300

2716

(3035350) Ketones [Presence] in Urine by Test strip

1725

14347

1.38

19.90

3.8

3.5

estimate

0.0

0.00

285

2646

(1002224) Polysomnography panel

226

1173

1.99

19.88

1.1

—

(3003338) MCHC [Mass/volume]

2827

25562

1.46

19.83

24.6

17.7

g/l

331.2

332.7

16.72

2808

25384

(3009261) Glucose [Presence] in Urine by Test strip

1745

14553

1.38

19.73

3.9

3.6

estimate

0.0

1.34

292

2612

(3004789) Transferrin [Mass/volume] in Serum or Plasma

621

4285

1.54

19.63

2.3

2.5

g/l

2.3

1.57

579

3982

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

435

2764

1.65

19.48

2.5

2.4

u/l

32.0

56.8

0.82

369

2379

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1242

9808

1.40

19.44

3.3

3.2

u/l

31.5

37.4

1.34

1186

9316

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3057

28109

1.52

19.41

6.2

5.7

mmol/mol

40.5

39.9

2.68

2868

25990

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

15.52

19.35

1.1

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

750

5401

1.49

19.31

2.8

3.1

mmol/l

2.5

0.20

660

4738

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

146

649

2.30

19.14

1.7

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

193

3.46

19.03

1.9

2.6

e6/l

581.4

539.7

0.21

165

(3026782) Osmolality of Urine

797

5827

1.47

18.97

3.0

2.7

mosm/kgh2o

555.0

553.9

0.04

673

4968

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1184

9312

1.40

18.84

2.7

2.5

u/l

54.8

58.4

2.14

1097

8602

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

435

2.58

18.62

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

147

665

2.26

18.50

1.6

—

(3015736) pH of Urine

1374

11105

1.38

18.46

3.5

3.3

—

5.7

—

(3016502) Oxygen saturation in Arterial blood

462

3024

1.60

18.30

7.0

8.1

95.5

95.8

0.48

442

2910

(3019060) Gas panel - Arterial blood

320

1904

1.75

18.26

3.7

5.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

378

2.66

18.00

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

325

1957

1.72

17.76

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1035

8027

1.40

17.63

2.8

2.7

umol/l

2614.2

5039.8

1.36

903

6964

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3419

32430

1.78

17.52

12.4

10.3

u/l

26.4

26.8

0.76

3324

31269

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

642

4564

1.49

17.44

1.6

1.4

—

(3032080) INR in Blood by Coagulation assay

1495

12325

1.36

17.42

8.7

9.2

inr

1.2

1.3

3.81

390

3451

(3021960) Folate [Moles/volume] in Serum or Plasma

906

6901

1.42

17.02

1.6

1.5

nmol/l

19.9

20.6

0.80

806

5859

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

281

1645

1.77

16.95

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

499

3389

1.55

16.76

2.7

2.8

umol/l

6.4

8.7

2.59

436

2962

(3011412) CD3 cells [#/volume] in Blood

280

2.86

16.56

1.9

2.5

e9/l

1.5

1.1

2.01

160

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

196

3.25

16.52

1.6

2.2

—

(3007461) Platelets [#/volume] in Blood

3516

33721

1.99

16.22

27.9

20.4

e9/l

262.7

247.5

34.76

3453

32860

(3035941) MCH [Entitic mass]

3516

33737

1.97

15.95

27.8

20.2

30.3

30.4

5.21

3483

33249

(3024731) MCV [Entitic volume]

3516

33738

1.97

15.93

27.8

20.3

91.2

0.08

3483

33253

(3026361) Erythrocytes [#/volume] in Blood

3516

33742

1.97

15.86

27.9

20.3

e12/l

4.5

2.51

3442

32778

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2264

20029

1.34

15.76

3.2

3.1

u/l

53.8

50.4

0.61

2129

18647

(3010813) Leukocytes [#/volume] in Blood

3516

33748

1.97

15.76

28.0

20.4

e9/l

7.3

6.7

41.75

3441

32778

(3002173) Hemoglobin [Mass/volume] in Arterial blood

425

2822

1.57

15.73

7.4

8.5

g/l

123.9

121.7

1.41

404

2719

(3000963) Hemoglobin [Mass/volume] in Blood

3516

33751

1.96

15.71

28.1

20.4

g/l

136.1

0.01

3485

33263

(3014111) Lactate [Moles/volume] in Serum or Plasma

395

2583

1.59

15.61

6.8

7.2

mmol/l

1.2

1.4

2.21

377

2492

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

379

2454

1.61

15.61

3.3

2.8

ng/l

141.7

198.5

3.76

334

2227

(40768443) Skin Pathology biopsy report

228

1288

1.82

15.50

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

534

3761

1.49

15.02

6.9

7.0

mmol/l

104.3

104.5

0.29

518

3676

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

8.04

14.89

1.1

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

618

4489

1.45

14.83

1.6

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

211

3.02

14.65

1.7

1.4

u/ml

32.4

20.0

0.86

(3027945) Reticulocytes/100 erythrocytes in Blood

485

3371

1.51

14.52

2.6

1.7

1.8

0.55

433

2989

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

207

3.03

14.50

1.5

2.2

12.6

14.9

0.76

(3026389) Candida sp identified in Specimen by Organism specific culture

337

2.56

14.39

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

385

2.45

14.38

1.0

1.1

g/l

1.4

1.5

1.70

347

(44790047)

303

2.64

14.30

1.6

1.5

—

(44790048)

303

2.64

14.30

1.6

1.5

—

(44790049)

303

2.64

14.30

1.6

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

12.77

14.25

1.6

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

121

570

2.16

13.86

4.1

3.6

57.7

57.5

0.08

121

570

(44806118)

303

2.61

13.78

1.6

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

189

1047

1.85

13.70

1.3

1.2

u/ml

0.5

1.2

0.99

(3012095) Magnesium [Moles/volume] in Serum or Plasma

653

4864

1.42

13.55

3.5

3.4

mmol/l

0.8

0.18

600

4552

(3008152) Bicarbonate [Moles/volume] in Arterial blood

294

1852

1.64

13.51

5.5

7.1

mmol/l

24.3

24.5

0.32

272

1726

(36660697) Celiac disease serology panel - Serum

337

2197

1.59

13.45

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

107

487

2.23

13.36

1.6

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

2961

27576

1.38

12.94

20.9

14.7

40.5

39.9

4.42

2216

19700

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

216

2.85

12.89

1.8

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1653

14229

1.29

12.84

3.9

4.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

624

4666

1.41

12.59

1.9

2.1

29.8

29.9

0.11

609

4532

(3013005) Retinol [Moles/volume] in Serum or Plasma

102

3.75

12.53

2.2

1.6

umol/l

1.8

2.0

0.45

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

4.85

12.36

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3143

29642

1.42

12.10

4.9

4.6

mmol/l

5.9

6.0

0.56

2911

27005

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

315

2075

1.57

12.00

1.8

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

6.58

11.91

1.1

u/ml

0.0

0.1

0.65

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

152

829

1.87

11.61

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

241

2.64

11.54

1.4

2.2

42.3

43.1

—

(3052851) Hemolysis interference index of Serum or Plasma

155

854

1.85

11.47

3.0

3.3

—

(3002032) Base excess in Venous blood by calculation

389

2708

1.49

11.46

4.2

3.7

mmol/l

2.2

1.8

1.00

322

2177

(3021447) Carbon dioxide [Partial pressure] in Venous blood

389

2709

1.49

11.44

4.2

3.7

kpa

5.9

5.8

0.49

375

2628

(3014765) Yersinia sp identified in Stool by Organism specific culture

151

832

1.85

11.18

1.2

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

473

3446

1.43

10.97

3.6

4.5

u/l

222.0

246.6

6.25

445

3255

(42529406) Shigella sp [Presence] in Stool by Culture

151

841

1.83

10.82

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

130

3.18

10.54

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

301

2.39

10.52

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

3.45

10.28

1.3

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

521

3905

1.39

10.23

23.5

24.8

inr

1.2

1.3

1.08

588

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.83

10.06

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

356

2512

1.46

9.77

2.6

e9/l

67.7

68.6

0.22

244

1888

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

281

2.37

9.72

1.5

1.7

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

7.39

9.70

1.0

u/ml

0.6

0.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

356

2516

1.46

9.69

2.1

2.6

g/l

65.9

66.5

0.68

328

2293

(3000991) Gas panel - Venous blood

347

2451

1.46

9.47

8.5

8.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

387

2.14

9.47

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

139

2.97

9.45

1.1

1.0

iu/ml

10.6

10.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

318

2212

1.48

9.39

3.5

2.9

kpa

4.7

4.6

0.12

304

2141

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

233

1520

1.57

9.28

9.3

10.2

mmol/l

24.9

24.1

3.13

209

1432

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

150

879

1.74

9.10

1.8

1.7

—

(3026008) Bacteria identified in Urine by Culture

1015

8488

1.27

9.09

3.0

3.1

—

(3020891) Body temperature

187

1163

1.64

9.09

4.0

4.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

15.62

9.02

1.1

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

151

891

1.72

8.94

2.1

2.3

g/l

0.1

0.0

0.84

142

822

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

305

2.25

8.92

1.6

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3222

30819

1.37

8.76

5.2

4.9

mmol/l

2.7

2.8

0.30

3003

28392

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

174

2.66

8.70

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

193

1231

1.60

8.48

4.4

5.4

0.9

0.80

178

1153

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

243

1639

1.52

8.34

9.3

10.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

128

2.91

8.27

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

105

570

1.87

8.24

1.2

u/ml

18.6

42.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

168

2.64

8.19

1.5

u/l

5.6

7.7

1.04

147

(3027273) Bicarbonate [Moles/volume] in Venous blood

212

1399

1.55

8.06

4.3

3.2

mmol/l

25.8

25.2

2.02

206

1353

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

140

835

1.70

8.01

2.1

2.3

g/l

0.0

0.50

132

769

(3009508) Creatinine [Moles/volume] in Urine

1122

9610

1.24

7.96

3.2

mmol/l

7.5

7.7

0.62

952

8080

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

244

2.32

7.90

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

244

2.32

7.90

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

244

2.32

7.90

1.4

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

295

2092

1.45

7.89

1.9

2.4

—

(3044640) Blood type and Crossmatch panel - Blood

1124

9637

1.24

7.88

2.5

2.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

253

1742

1.49

7.88

3.7

3.5

mmol/l

1.6

1.8

0.29

194

1282

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

191

1239

1.57

7.84

4.4

5.3

1.6

0.34

176

1160

(3025941) Bacteria identified in Stool by Culture

234

1588

1.51

7.82

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

138

826

1.70

7.81

2.1

2.3

g/l

0.0

0.00

131

768

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

175

1114

1.60

7.78

2.1

2.4

g/l

10.3

0.03

153

948

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

125

731

1.73

7.69

1.2

u/ml

3.3

7.8

1.20

129

(3009343) pH of Capillary blood

259

1804

1.47

7.61

3.7

3.6

7.4

1.05

208

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1197

1.57

7.47

2.2

2.4

g/l

7.3

0.04

143

905

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

123

723

1.73

7.45

1.2

u/ml

1.5

6.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

143

877

1.66

7.40

3.3

4.2

mmol/l

3.9

0.17

134

818

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

183

1196

1.56

7.29

2.2

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

183

1196

1.56

7.29

2.2

2.4

g/l

4.3

3.8

0.91

140

861

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

103

581

1.80

7.20

1.2

u/ml

19.4

3.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1266

11083

1.22

7.09

4.1

3.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

137

842

1.65

7.05

1.5

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

259

1832

1.45

7.04

3.8

3.6

kpa

5.1

5.2

0.29

243

1690

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

184

1214

1.54

7.03

1.9

2.0

ug/l

1.4

2.6

1.10

162

1083

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

172

1121

1.56

6.95

2.3

2.4

g/l

3.0

3.1

0.32

142

885

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

159

1018

1.59

6.93

2.2

2.4

g/l

1.5

1.0

0.34

146

883

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

189

2.40

6.93

1.1

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

214

2.31

6.92

2.0

2.5

e6/l

608.3

669.9

0.27

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.02

6.90

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

959

8187

1.23

6.83

1.6

mmol/l

1.4

0.25

815

6869

(3039162) Centromere protein B Ab [Units/volume] in Serum

334

2.02

6.81

1.3

1.2

u/ml

48.8

42.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

203

1382

1.50

6.72

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3153

30278

1.29

6.66

4.6

4.4

mmol/l

4.7

0.51

2947

28065

(3004119) Hemoglobin [Mass/volume] in Venous blood

255

1818

1.43

6.65

3.8

3.0

g/l

133.2

128.9

2.43

250

1766

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

187

2.37

6.62

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

118

711

1.68

6.57

1.5

1.6

e6/l

13042.4

13789.4

0.04

513

(3017732) Neutrophils [#/volume] in Blood

284

2069

1.40

6.57

2.5

3.1

e9/l

4.6

4.1

2.11

219

1611

(3019150) Specific gravity of Urine by Refractometry

748

6240

1.25

6.55

4.1

3.9

kg/l

1.0

0.54

933

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

346

2608

1.36

6.50

2.4

2.2

ug/l

6.2

8.1

1.51

310

2313

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

183

2.37

6.46

1.5

1.3

titre

532.0

186.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

164

1077

1.55

6.43

1.6

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3132

30077

1.28

6.43

4.6

4.4

mmol/l

1.5

1.4

5.53

2917

27712

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

146

937

1.58

6.33

2.1

2.2

g/l

36.9

37.7

0.91

134

808

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

221

1550

1.45

6.31

2.6

2.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

167

2.41

6.27

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

202

1397

1.47

6.20

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3034

29054

1.25

6.19

4.1

4.0

mmol/l

1.3

1.18

2798

26599

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

870

7419

1.23

6.17

2.5

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

135

856

1.60

6.17

1.5

1.6

iu/ml

0.1

1.3

0.61

162

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.92

6.15

1.6

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

169

2.38

6.12

1.4

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

127

799

1.61

6.00

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

204

2.22

5.87

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

204

2.22

5.87

1.1

—

(3044941) Cell count panel - Synovial fluid

477

1.78

5.81

1.5

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

205

2.21

5.81

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1046

9129

1.20

5.81

3.4

3.3

mg/l

534.1

293.7

0.77

662

5785

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

161

2.37

5.79

1.5

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

590

1.70

5.79

7.0

5.6

iu/ml

283.6

3157.5

0.61

(3005011) Chlamydia sp Ab [Titer] in Serum

4.39

5.76

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

154

1024

1.53

5.74

2.0

2.4

ug/l

195.8

720.0

1.90

145

973

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

2.73

5.68

1.1

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

207

2.19

5.68

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

207

2.19

5.68

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

207

2.19

5.68

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

228

2.12

5.60

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

238

1733

1.40

5.55

3.1

3.3

pmol/l

4.5

4.4

0.32

210

1532

(3021901) Oxygen saturation in Capillary blood

507

1.73

5.53

3.2

2.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

196

1382

1.44

5.48

3.9

4.1

mmol/l

24.2

24.0

0.24

172

1256

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.96

5.44

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.96

5.44

1.4

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.96

5.44

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

436

1.78

5.41

1.3

1.2

u/ml

2.7

4.8

1.67

189

(3047181) Lactate [Moles/volume] in Blood

141

935

1.53

5.35

5.2

6.4

mmol/l

1.2

1.3

0.75

124

823

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

161

2.31

5.34

1.5

1.6

—

(3022313) Gas panel - Capillary blood

190

1340

1.44

5.31

3.7

3.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

485

3938

1.27

5.31

5.4

6.1

mmol/l

1.0

0.24

455

3672

(3028626) Oxygen [Partial pressure] in Capillary blood

606

1.65

5.27

3.2

2.9

kpa

8.3

8.0

0.70

556

(3015235) Bicarbonate [Moles/volume] in Capillary blood

112

708

1.60

5.24

3.1

mmol/l

24.4

24.7

0.51

612

(3006184) Hemoglobin [Mass/volume] in Capillary blood

100

617

1.64

5.16

2.7

2.2

g/l

129.1

129.2

0.01

443

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

364

2863

1.30

5.12

2.2

g/l

0.2

0.55

345

2673

(3036489) Thrombin time

158

1085

1.48

5.09

1.9

2.0

23.0

21.5

0.48

138

960

(3039000) Anion gap in Blood

107

677

1.60

5.00

5.3

7.4

mmol/l

11.2

0.00

607

(3018572) Chloride [Moles/volume] in Blood

107

678

1.60

4.98

5.3

7.4

mmol/l

105.6

105.3

0.26

608

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

2.58

4.96

1.9

2.0

u/ml

1650.0

29537.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

317

2458

1.32

4.95

2.5

2.6

ml/min/173m2

71.0

66.4

1.32

120

967

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

192

1379

1.41

4.88

3.1

2.5

1.2

0.03

192

1367

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

188

1348

1.42

4.83

3.1

2.4

0.6

0.7

0.19

183

1292

(3008898) HLA-B27 [Presence]

132

884

1.51

4.82

1.0

1.1

—

(4094501)

131

876

1.51

4.82

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

289

2222

1.33

4.80

3.5

4.0

ng/l

92.3

92.6

0.01

247

1924

(3003740) Influenza virus B Ag [Presence] in Specimen

423

1.74

4.78

1.2

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

397

3187

1.28

4.77

1.4

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

124

823

1.52

4.73

2.1

2.3

185.2

193.4

0.46

119

783

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

441

1.72

4.67

1.3

1.2

u/ml

3.3

3.9

0.20

148

(1616796) Gas panel - Central venous blood

101

642

1.59

4.66

4.2

3.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

309

2411

1.31

4.63

1.5

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

422

1.72

4.55

1.3

1.1

—

(3012501) Base excess in Blood by calculation

103

664

1.57

4.49

4.3

4.5

mmol/l

2.3

2.6

0.69

455

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

216

2.00

4.40

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

287

1.86

4.37

2.6

3.3

—

(3010421) pH of Blood

117

784

1.51

4.30

4.1

4.2

7.4

0.59

102

657

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

8.91

4.28

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

145

2.22

4.27

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

145

2.22

4.27

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

145

2.22

4.27

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

145

2.22

4.27

1.5

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

261

1.89

4.25

1.9

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

120

2.34

4.24

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

280

2184

1.31

4.22

1.9

—

(3034770) Mitochondria Ab [Titer] in Serum

120

812

1.49

4.21

1.2

titre

1410.0

1175.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1076

9630

1.17

4.21

4.1

4.0

mg/mmol

8.9

9.1

0.05

681

6128

(3028433) Virus identified in Specimen by Culture

2.57

4.21

1.0

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

242

1854

1.33

4.15

1.4

1.3

au/ml

42.1

53.0

0.35

(3037756) Immunofixation for Serum or Plasma

615

1.56

4.10

1.4

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

266

2070

1.31

4.09

1.3

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

878

7753

1.17

4.05

4.4

3.9

estimate

0.0

1.28

294

2582

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

111

2.35

3.99

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

111

2.35

3.99

1.6

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.94

3.97

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

115

782

1.49

3.96

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

304

1.79

3.96

2.0

3.6

55.2

56.9

0.23

185

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

549

1.58

3.95

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

261

2036

1.30

3.95

2.4

au/ml

24.3

25.3

0.05

110

(3020779) Urea [Moles/volume] in Serum or Plasma

341

2756

1.26

3.90

6.4

7.7

mmol/l

9.7

10.1

0.36

318

2633

(3004809) Band form neutrophils/100 leukocytes in Blood

505

1.60

3.86

2.6

3.6

1.3

1.4

0.10

382

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

113

2.31

3.84

1.7

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

304

2434

1.27

3.77

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

640

5539

1.19

3.73

1.9

1.7

nmol/l

1127.6

1149.8

0.26

481

4162

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

266

1.82

3.73

1.1

1.2

—

(4306422)

424

1.64

3.72

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

535

1.56

3.69

1.1

1.2

u/ml

258.0

279.5

0.26

324

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

319

1.74

3.67

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

616

1.52

3.66

3.4

2.4

15.9

16.2

0.27

301

(3035637) Corticotropin [Mass/volume] in Plasma

327

1.72

3.66

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

849

1.44

3.59

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1031

9292

1.15

3.58

4.4

4.2

20.9

21.9

1.14

482

4475

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1266

11575

1.14

3.58

5.0

4.9

ug/l

3.3

3.6

0.10

1132

10412

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

7.79

3.56

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

135

969

1.41

3.54

2.3

3.6

mg/l

63.8

59.8

0.09

788

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.30

3.51

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.30

3.51

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

172

1.99

3.48

2.6

2.8

40.3

38.2

0.23

(3017446) Testosterone [Moles/volume] in Serum or Plasma

308

2495

1.26

3.48

2.4

2.2

nmol/l

13.0

0.01

268

2209

(3021788) Differential panel - Synovial fluid

520

1.55

3.45

1.5

—

(4035726)

335

2743

1.24

3.44

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

167

1248

1.35

3.44

2.1

1.9

—

(3051651) Icteric interference index of Serum or Plasma

173

1.97

3.43

2.4

3.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

121

857

1.43

3.43

1.3

1.4

ug/g

294.4

281.2

0.28

490

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.77

3.42

1.4

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

126

900

1.41

3.41

2.1

94.9

90.8

1.37

116

847

(21494434) Karyotype in Bone marrow

289

1.74

3.41

1.4

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

134

968

1.40

3.40

2.3

3.6

mg/l

28.4

53.7

2.31

787

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

522

1.54

3.40

1.2

1.4

u/ml

114.2

119.2

0.14

(3013512) EKG study

991

8945

1.15

3.34

4.1

3.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

130

938

1.40

3.33

2.3

3.6

ratio

3.8

2.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

226

1.82

3.28

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.34

3.24

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

3.20

1.1

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

573

1.49

3.13

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.63

3.13

1.5

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

312

1.68

3.13

1.2

1.1

95.2

95.8

0.05

295

(40761535) Cells panel - Urine sediment

295

2409

1.24

3.13

3.6

3.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

406

1.59

3.10

1.1

122.5

114.6

1.54

370

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.81

3.08

2.9

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

450

3843

1.19

3.05

1.4

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

585

1.48

3.04

1.6

—

(40757373) Influenza virus identified in Isolate

2.59

3.04

1.4

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

5.84

3.02

1.1

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

114

820

1.40

3.00

1.2

titre

88.5

94.7

0.10

(3016650) Hepatitis A virus Ab [Presence] in Serum

477

1.52

2.90

1.1

—

(4268621)

305

1.65

2.85

2.6

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

153

1164

1.33

2.85

4.2

3.7

mmol/l

25.0

24.8

0.51

146

1075

(3008757) Leukocyte morphology finding [Identifier] in Blood

321

1.63

2.84

3.4

4.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.06

2.80

1.3

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

547

1.47

2.79

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.92

2.77

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

145

1.94

2.74

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

145

1.94

2.74

1.5

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.76

2.67

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

3.76

2.67

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

586

1.44

2.66

1.2

1.4

—

(3045142) Bone marrow Pathology biopsy report

367

1.56

2.64

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

227

1839

1.25

2.62

1.2

iu/ml

110.5

150.5

1.02

667

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

377

3215

1.19

2.62

1.7

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

497

1.48

2.62

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.66

2.62

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

149

1145

1.31

2.62

1.8

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

155

1.88

2.61

2.1

2.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

148

1.90

2.60

1.0

1.6

u/field

2.3

1.7

0.51

105

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

127

1.98

2.60

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

102

743

1.38

2.55

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

719

1.39

2.52

2.1

3.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

141

1085

1.31

2.47

1.7

mg/l

6.1

3.5

1.20

117

756

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

463

1.48

2.46

1.8

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.24

2.44

1.3

43.6

31.7

—

(3024263) Appearance of Synovial fluid

159

1.83

2.43

1.6

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

197

1586

1.26

2.43

2.8

e6/l

0.1

0.3

2.28

192

1547

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

409

3538

1.18

2.42

1.6

1.8

1.4

1.5

1.57

347

3109

(3009214) Lutropin [Units/volume] in Serum or Plasma

700

1.38

2.40

1.5

1.4

u/l

10.9

9.2

0.51

572

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

434

1.48

2.37

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.76

2.37

1.8

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

2.21

2.37

1.0

—

(3023410) Appearance of Cerebral spinal fluid

291

1.59

2.33

1.4

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

237

1.65

2.31

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

143

1114

1.30

2.31

3.0

3.4

u/ml

2496.7

3908.2

0.16

119

949

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.05

2.31

2.6

2.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.18

2.30

1.6

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

850

7779

1.12

2.22

3.6

3.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

111

840

1.33

2.22

1.2

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.34

2.18

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

377

1.49

2.17

1.4

mu/l

43.2

57.4

0.38

329

(3021387) Prolactin [Units/volume] in Serum or Plasma

108

818

1.33

2.15

1.8

1.7

mu/l

358.8

294.0

0.76

101

747

(3027456) Digoxin [Moles/volume] in Serum or Plasma

519

1.41

2.15

3.2

3.1

nmol/l

0.8

0.13

399

(3045716) Anion gap in Serum or Plasma

144

1.81

2.14

1.8

2.5

mmol/l

8.4

9.5

1.08

112

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

504

1.42

2.11

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

471

1.43

2.10

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

292

1.55

2.08

5.1

5.0

u/ml

17.0

75.8

1.45

(1001926) Buprenorphine [Presence] in Urine by Screen method

660

1.36

2.05

1.2

2.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

127

993

1.29

2.03

1.8

—

(3002256) Pathology report gross observation

455

4027

1.15

2.02

1.3

—

(3011288) Drugs identified in Urine by Screen method

551

1.39

2.02

1.5

3.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

370

3226

1.16

2.02

3.9

4.1

ug/l

46.0

25.7

0.27

308

2611

(21491868) Cryoglobulin [Mass/volume] in Serum

111

1.90

2.00

1.1

1.2

g/l

—

0.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

170

1.71

2.00

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

120

934

1.29

1.99

1.9

1.8

nmol/l

40.4

41.8

0.30

114

901

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

352

1.48

1.99

1.5

51.8

58.4

0.46

222

(3035320) C reactive protein [Mass/volume] in Body fluid

201

1.65

1.98

2.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

1.74

1.96

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

462

1.41

1.94

1.2

—

(3017569) Oxygen content in Arterial blood

149

1.75

1.94

2.6

2.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.55

1.94

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

196

1.64

1.89

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

151

1.73

1.86

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

197

1.63

1.86

1.1

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.86

1.86

1.1

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.98

1.84

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

277

1.52

1.84

1.1

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.21

1.84

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

4.17

1.82

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.06

1.80

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

720

1.31

1.79

1.4

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

133

1066

1.26

1.78

1.4

iu/l

28.5

30.4

0.29

112

923

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

116

1.82

1.78

1.2

2.0

umol/l

55.7

165.0

1.97

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

732

6728

1.11

1.76

3.2

3.0

ug/l

0.6

0.8

6.97

500

4453

(3017704) Immunofixation for Urine

177

1.64

1.76

1.3

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.90

1.75

2.4

2.1

ug/l

0.7

1.0

0.67

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.30

1.70

1.3

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

552

1.35

1.70

1.6

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

291

1.48

1.69

1.3

e6/l

233923.1

114359.4

0.22

212

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

375

1.42

1.67

1.2

1.3

mmol/l

7.7

7.1

0.49

276

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

122

977

1.26

1.67

1.7

1.8

—

(4027681)

165

1.64

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.25

1.63

1.5

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

714

1.30

1.62

2.0

1.8

iu/l

5.6

4.9

0.23

254

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

172

1436

1.21

1.60

1.5

1.7

g/l

1.7

1.5

2.21

145

1233

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.07

1.59

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

165

1376

1.21

1.56

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

107

1.78

1.54

3.2

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

107

1.78

1.54

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

176

1.60

1.54

1.1

u/l

94.1

81.6

0.29

150

(3028717) Thiamine [Mass/volume] in Blood

2.43

1.53

1.0

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.28

1.53

2.2

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

315

1.43

1.52

3.5

6.2

mmol/l

7.2

0.04

264

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

374

1.40

1.52

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

169

1.60

1.51

1.1

u/l

16.3

17.5

0.09

141

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

356

3167

1.14

1.51

3.7

3.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.86

1.50

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

375

1.39

1.50

2.5

2.3

mg/l

21.5

23.9

0.11

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

149

1237

1.21

1.49

1.9

1.8

—

(3004451) EKG impression Narrative

155

1.62

1.46

1.4

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

293

1.44

1.46

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.88

1.44

1.7

1.3

ug/l

8.4

9.2

0.53

(3027944) Amphetamines [Presence] in Urine

104

834

1.25

1.44

1.2

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.12

1.44

1.4

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

665

1.28

1.44

1.2

1.3

e6/l

48.1

24.0

0.27

512

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

665

1.28

1.44

1.3

1.4

e6/l

321.8

1056.4

1.26

541

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

277

2432

1.15

1.44

3.3

4.1

mmol/l

1.2

0.01

250

2126

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.92

1.43

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.92

1.43

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.92

1.43

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.92

1.43

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.31

1.43

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

347

1.39

1.38

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.61

1.36

1.2

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

256

1.45

1.35

2.5

1.8

umol/l

6.6

8.3

0.26

176

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

240

1.46

1.34

1.9

2.1

u/field

1.5

2.0

0.38

(3027008) Opiates [Presence] in Urine

105

852

1.24

1.33

1.2

2.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.04

1.32

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.97

1.32

1.1

1.3

—

(3028300) Cannabinoids [Presence] in Urine

105

856

1.23

1.29

1.3

2.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.78

1.28

2.2

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

370

1.36

1.27

1.6

1.9

ug/l

14.5

25.9

2.41

364

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

354

1.36

1.25

1.5

1.4

pmol/l

282.4

255.5

0.24

278

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

537

1.29

1.25

2.2

3.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

211

1.47

1.25

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

610

1.27

1.22

1.2

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

763

1.24

1.21

1.2

1.3

mg/l

595.6

522.6

0.42

721

(4281824)

301

0.63

1.21

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

271

1.41

1.21

1.7

1.3

nmol/l

1.2

1.4

0.72

244

(3045424) Erythrocytes [Presence] in Urine

531

1.29

1.21

1.4

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

103

845

1.23

1.21

1.3

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.88

1.18

1.6

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

173

1.51

1.17

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.14

0.0

1.2

—

(3016879) Cocaine [Presence] in Urine

790

1.22

1.11

1.2

2.2

—

(3012565) Volume of 24 hour Urine

144

1.53

1.08

1.7

2.6

2015.7

1914.1

0.17

128

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

775

1.22

1.08

1.3

miu/ml

172.1

205.7

0.40

338

(3001019) Free T4 and TSH panel - Serum or Plasma

165

1431

1.16

1.07

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.93

1.06

1.9

1.8

umol/l

13.9

18.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

129

1.55

1.05

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

331

1.33

1.05

1.5

1.3

u/l

23.3

27.5

0.35

270

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.71

1.05

1.1

1.3

124.7

85.5

—

(3019977) pH of Arterial blood

162

1.48

1.04

2.3

2.6

7.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.06

1.02

4.3

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

308

1.33

1.00

1.1

u/l

61.1

58.4

0.14

204

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

665

1.22

0.99

1.2

mmol/l

3.9

3.8

0.33

622

(3003181) Sodium [Moles/volume] in Urine

512

1.25

0.98

1.3

mmol/l

69.1

62.8

0.56

412

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.18

0.98

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

362

1.30

0.97

3.5

2.4

mmol/l

4.1

0.04

355

(3035285) Chloride [Moles/volume] in Venous blood

362

1.30

0.97

3.5

2.4

mmol/l

105.9

105.6

0.18

355

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.95

0.97

8.7

10.0

—

(3037121) Protein [Mass/volume] in Urine

124

1063

1.17

0.96

2.7

3.0

g/l

0.2

0.3

0.55

440

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.22

0.93

1.0

1.2

—

(3034426) Prothrombin time (PT)

101

1.59

0.93

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

201

1.40

0.91

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

193

1.40

0.90

7.3

6.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

474

1.25

0.89

2.0

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.07

0.89

2.7

2.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.58

0.87

1.2

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

136

1.47

0.86

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.82

0.85

1.4

1.3

ug/l

100.6

133.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

120

1.50

0.85

1.3

1.7

mmol/l

9.3

8.1

0.93

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

1.42

0.84

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.76

0.83

1.1

1.4

113.3

106.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

222

1.35

0.83

1.1

mg/l

44.7

44.1

0.02

181

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

214

1.36

0.82

1.0

1.1

mg/l

223.5

300.8

2.35

182

(3028707) Methadone [Presence] in Urine by Screen method

364

1.27

0.81

1.3

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

118

1026

1.16

0.80

2.8

3.2

u/ml

0.4

0.3

0.64

578

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

122

1.48

0.80

1.1

105.0

93.0

0.79

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

277

1.30

0.78

1.4

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

281

0.71

0.78

1.2

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.59

0.78

1.1

101.0

86.2

—

(3038026) Centromere Ab [Units/volume] in Serum

234

1.33

0.77

1.1

1.2

—

52.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

217

1.34

0.76

1.1

1.2

—

3.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

217

1.34

0.76

1.1

1.3

mmol/l

11.7

12.0

0.10

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

124

1.45

0.75

1.0

1.1

iu/ml

148.8

194.5

0.73

124

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.08

0.74

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

158

1.39

0.74

1.1

ratio

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

172

0.64

0.73

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

352

1.25

0.73

1.2

1.3

nmol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.55

0.71

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

353

1.25

0.71

3.7

2.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.92

0.70

1.8

2.1

mg/l

0.8

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

186

1.35

0.70

1.6

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

768

1.16

0.69

2.3

ug/min

111.2

100.7

0.10

463

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.51

0.69

2.2

1.6

146.1

171.7

0.69

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

391

1.23

0.69

5.5

6.5

mg/l

11.4

11.9

0.43

366

(3014891) Appearance of Pleural fluid

1.67

0.68

1.4

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.67

0.68

2.0

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.53

0.68

1.2

1.1

—

(4034850)

109

957

1.14

0.68

10.1

9.6

—

(3051593) INR in Capillary blood by Coagulation assay

144

1.39

0.67

8.4

12.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

0.59

0.67

1.0

1.4

—

2284600.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

356

1.24

0.67

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

348

1.24

0.66

1.5

1.4

—

(3035880) pH of Pleural fluid

171

1.35

0.65

1.4

—

(40765096) Chromosome analysis panel by Banding

103

1.46

0.65

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

663

6334

1.06

0.64

1.7

pmol/l

27370738.2

31694727.9

0.08

559

5247

(3009871) Measles virus Ab [Titer] in Serum

1.48

0.64

1.5

1.7

—

(21494755) Public health laboratory ask at order entry panel

288

2676

1.08

0.64

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

350

1.23

0.63

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

278

1.26

0.63

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

297

1.25

0.62

1.3

1.2

—

(44806071)

1.67

0.61

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.48

0.60

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

389

1.21

0.60

1.1

1.0

u/ml

1.6

3.7

1.88

169

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

672

0.85

0.60

2.6

3.5

u/ml

51.8

782.5

1.22

620

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.59

0.0

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.44

0.59

1.6

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.58

1.7

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.46

0.58

1.7

2.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.72

0.57

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.48

0.57

1.5

—

(3025130) Human papilloma virus identified in Specimen

328

1.22

0.57

1.6

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

150

1.34

0.55

1.4

1.7

—

6.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

227

0.75

0.53

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

372

3929

0.94

0.52

4.4

4.5

32.6

32.3

0.23

268

2655

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

117

1.37

0.52

1.2

1.6

51.1

62.9

0.57

(3024471) HLA-A [Type]

0.61

0.52

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

296

1.22

0.51

2.8

2.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.39

0.50

1.0

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

699

1.13

0.48

2.4

2.2

—

(3000012) Reticulocyte production index

154

1.30

0.48

1.3

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

253

1.23

0.48

1.3

1.4

pmol/l

67.9

188.5

0.50

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

226

1.24

0.48

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.49

0.47

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.46

0.46

1.3

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

191

1.26

0.46

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

120

1.33

0.46

1.5

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

833

0.89

0.45

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.59

0.45

1.8

1.5

g/l

16.5

12.2

—

(3003694) ABO and Rh group [Type] in Blood

807

8320

0.96

0.45

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

175

0.74

0.44

24.6

13.0

nmol/l

902.6

840.3

0.17

168

(3009466) Valproate [Moles/volume] in Serum or Plasma

427

0.84

0.44

4.3

5.3

umol/l

341.7

363.9

0.44

371

(3015183) Erythrocyte sedimentation rate

152

0.72

0.44

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

649

1.13

0.43

4.9

3.4

mg/l

22.8

28.0

0.59

391

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.61

0.43

1.2

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

393

0.84

0.43

1.6

1.4

—

(3024928) Oxygen saturation in Venous blood

641

1.13

0.42

3.1

2.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

162

0.74

0.42

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

733

0.88

0.42

1.1

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.63

0.42

1.2

—

17.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

327

0.82

0.41

1.4

1.5

nmol/l

0.2

0.3

2.63

254

(3006653) Thiamine [Moles/volume] in Blood

149

1.28

0.41

1.2

nmol/l

142.2

136.3

0.26

149

(3022621) pH of Urine by Test strip

211

1980

1.07

0.41

3.2

3.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

380

0.84

0.41

1.7

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

681

1.12

0.40

2.0

2.1

u/l

4985.2

4025.5

0.11

281

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

361

1.17

0.40

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

105

0.67

0.39

1.9

1.3

umol/l

2.4

4.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

335

0.83

0.39

1.6

1.7

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.39

0.0

1.0

—

79.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

494

1.14

0.39

1.1

iu/ml

4.0

1251.1

—

105

(3008295) Osmolality of Serum or Plasma

313

0.83

0.38

1.1

1.3

mosm/kgh2o

280.5

279.4

0.11

243

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.39

0.38

2.0

1.4

72.7

74.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

216

2037

1.06

0.38

1.5

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

387

0.85

0.37

1.6

1.4

—

(4133840)

1.39

0.36

1.4

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

639

1.11

0.36

2.2

1.9

nmol/l

1.0

0.8

1.39

533

(21494890) Protein electrophoresis panel - 24 hour Urine

318

1.17

0.36

1.3

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.43

0.35

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

395

0.86

0.35

1.6

1.4

—

(3016228) CD19 cells/100 cells in Blood

126

1.27

0.35

1.5

2.0

5.1

9.3

1.77

120

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.40

0.35

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

283

1.17

0.34

1.3

1.5

—

(3014271) Vancomycin [Susceptibility]

144

0.76

0.33

2.8

2.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.70

0.33

5.8

7.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

381

0.86

0.32

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

381

0.86

0.32

1.6

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

110

1.27

0.31

1.2

1.0

—

(4146454)

337

0.86

0.31

2.5

2.6

—

(40768446) Kidney Pathology biopsy report

129

1.24

0.30

1.4

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

185

1.19

0.29

1.1

nmol/l

4.7

5.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

396

3829

1.04

0.29

8.1

6.6

—

(3020491) Glucose [Moles/volume] in Blood

223

1.17

0.28

1.7

1.9

mmol/l

6.4

6.9

0.98

150

(3049717) Cytology report of Urine Cyto stain

131

1232

1.07

0.28

2.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

186

1.18

0.27

1.3

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

792

0.92

0.27

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.70

0.26

1.2

1.3

—

(3019225) pH of Specimen

324

3130

1.04

0.25

4.0

4.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

169

1.18

0.25

1.1

u/l

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

132

1.21

0.25

1.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

282

1.14

0.25

1.6

1.4

37.5

30.1

0.40

173

(3035933) Granulocytes/100 leukocytes in Blood

1.22

0.25

1.1

1.8

—

(3004775) Volume in Urine collected for unspecified duration

254

1.14

0.25

2.5

2.1

735.9

622.0

0.69

172

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

454

1.10

0.25

1.6

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.71

0.24

1.0

1.1

—

(40768793) Breast Pathology biopsy report

641

0.92

0.23

1.2

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

671

0.92

0.23

2.3

3.0

umol/l

29.8

37.0

1.72

571

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.28

0.23

1.0

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

342

1.11

0.22

1.2

—

(3045788) Cell count panel - Pleural fluid

285

1.12

0.22

1.6

1.4

—

(3024932) HLA-DR beta [Type]

0.74

0.22

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

280

2708

1.04

0.22

1.7

1.8

—

(3006462) Nitrate [Presence] in Urine

144

1.18

0.22

2.6

3.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

191

1.15

0.21

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

13.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

420

4096

1.03

0.21

1.5

1.4

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.1

—

8.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

173

1.16

0.21

1.4

1.3

nmol/l

1.1

1.2

0.26

126

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.20

0.0

5.1

—

387.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

422

1.09

0.20

1.5

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

664

1.07

0.20

1.5

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.22

0.20

3.7

5.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

229

0.87

0.20

1.1

1.5

umol/l

13.4

13.2

0.05

217

(3023199) Leukocytes [#/volume] in Pleural fluid

365

1.10

0.19

1.5

1.4

e6/l

3532.2

1882.1

0.83

265

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

423

1.09

0.19

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

423

1.09

0.19

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.18

0.19

1.2

1.8

ng/l

74.8

139.8

—

(3022689) Creatine [Moles/volume] in Urine

1.22

0.19

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

424

1.09

0.18

1.5

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

109

1.19

0.18

1.2

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

280

1.11

0.18

2.7

2.9

mg/l

40.6

35.3

0.06

220

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.19

0.18

1.9

1.2

—

156.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.17

0.17

2.3

2.0

—

(3044927) Protein electrophoresis panel - Urine

320

1.09

0.17

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

349

1.09

0.17

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

152

0.85

0.16

1.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

148

1.15

0.16

4.5

3.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.16

0.16

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1072

10840

0.98

0.16

2.8

2.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.13

0.16

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

214

0.89

0.15

2.0

ug/l

2.3

3.1

0.64

186

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.78

0.15

5.8

8.0

—

(3020650) Glucose [Presence] in Urine

0.75

0.15

1.3

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

140

0.86

0.15

1.8

2.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

102

1.18

0.15

3.2

7.3

mmol/l

24.0

25.0

0.37

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.10

0.15

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

236

1.10

0.14

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.08

0.14

1.1

—

(4211845)

160

1.13

0.14

2.6

3.3

—

(3042733) HLA Ab [Presence] in Serum

0.82

0.13

2.1

4.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

334

1.08

0.13

1.4

e6/l

46083.0

86542.7

0.61

204

(3000330) Specific gravity of Urine by Test strip

155

1502

1.03

0.13

4.2

3.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

175

1801

0.97

0.13

1.4

—

(40768806) Pleura Pathology biopsy report

325

1.08

0.13

1.3

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.17

0.13

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

805

1.04

0.12

3.1

mg/l

1.5

1.6

0.27

740

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

374

0.94

0.11

1.3

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

105

1.14

0.11

1.3

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

730

0.96

0.11

1.8

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

505

1.05

0.10

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

880

1.03

0.10

1.6

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.14

0.10

1.0

—

(40761536) Microorganisms panel - Urine sediment

246

2505

0.98

0.09

4.8

3.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

238

0.92

0.09

1.0

ng/l

48.9

44.8

0.19

155

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

237

0.93

0.09

1.0

ng/l

355.7

324.7

0.25

158

(3051101) Glucose [Moles/volume] in Cord blood

1.07

0.08

6.8

6.9

—

(4024509)

302

1.06

0.08

1.5

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

312

1.06

0.08

2.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

236

0.93

0.08

1.0

ng/l

757.2

675.6

0.23

151

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.84

0.07

1.3

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.83

0.07

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.87

0.07

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.85

0.07

1.1

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.85

0.07

1.3

1.1

—

(44806420)

0.82

0.07

2.0

2.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.07

0.07

1.0

1.1

—

(3048879) Bone marrow aspiration report

1.02

0.07

1.8

1.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.89

0.06

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

111

0.90

0.06

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

297

1.04

0.05

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

313

0.96

0.05

1.3

—

(3012441) Differential panel - Pleural fluid

313

0.96

0.05

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

150

1.07

0.04

1.3

1.6

—

(3011648) Oxygen content in Venous blood

249

1.04

0.04

2.6

2.0

12.8

11.2

0.77

249

(3016038) Potassium [Moles/volume] in Urine

190

0.95

0.04

1.1

mmol/l

38.2

34.7

0.39

166

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

617

1.02

0.03

1.6

1.5

pmol/l

86.3

186.5

2.31

607

(3047189) Immunofixation for 24 hour Urine

159

0.94

0.03

1.3

1.5

—

(40768441) Liver Pathology biopsy report

227

0.97

0.01

1.5

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

152

0.99

0.00

1.1

1.2

—

69.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

192

0.99

0.00

1.4

1.6

u/l

9.9

7.0

0.27

(4198724)

1.05

0.00

1.1

1.6

—

(3006270) Folate [Moles/volume] in Blood

262

0.99

0.00

1.0

1.2

nmol/l

395.4

367.6

0.37

226

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

139

1.01

0.00

2.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

181

0.99

0.00

1.2

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

279

1.00

0.00

1.7

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

244

0.98

0.00

1.7

1.6

g/l

0.8

1.0

1.27

244

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.04

0.00

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

186

1.02

0.00

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

317

1.01

0.00

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

743

1.00

0.00

5.3

4.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

117

1.03

0.00

1.2

1.1

miu/ml

1270.3

1541.7

0.37

117

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

133

0.98

0.00

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

133

0.98

0.00

1.2

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

147

1.02

0.00

1.5

1.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.1

—

3246.7

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.5

—

0.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

5.5

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

7.3

—

114.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.8

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.86

0.00

1.4

2.7

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.92

0.00

1.3

1.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.88

0.00

3.8

2.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

118.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.94

0.00

4.0

1.3

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.01

0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint ASTHMA_EOSINOPHIL_SUGG and mortality.

Females

Parameter	HR [95% CI]	p-value
ASTHMA_EOSINOPHIL_SUGG	0.961 [0.87, 1.07]	0.46
Birth year	0.995 [0.99, 1.0]	0.228

During the follow-up period (1.1.1998 — 31.12.2019), 715 out of 6298 females with ASTHMA_EOSINOPHIL_SUGG died.

Males

Parameter	HR [95% CI]	p-value
ASTHMA_EOSINOPHIL_SUGG	0.787 [0.72, 0.86]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.077

During the follow-up period (1.1.1998 — 31.12.2019), 1120 out of 7644 males with ASTHMA_EOSINOPHIL_SUGG died.

Mortality risk

Mortality risk for people of age

years, who have ASTHMA_EOSINOPHIL_SUGG.

N-year risk	Females	Males
1	0.075%	0.185%
5	0.543%	1.05%
10	1.386%	2.583%
15	2.677%	5.032%
20	4.728%	8.745%

Relationships between endpoints

↥

Index endpoint: ASTHMA_EOSINOPHIL_SUGG – Suggestive for eosinophilic asthma

GWS hits: 25

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Suggestive for eosinophilic asthma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints